Assessing	O
Cholesterol	O
Storage	O
in	O
Live	O
Cells	O
and	O
C	B-OG
.	I-OG
elegans	I-OG
by	O
Stimulated	O
Raman	O
Scattering	O
Imaging	O
of	O
Phenyl	O
-	O
Diyne	O
Cholesterol	O

These	O
authors	O
contributed	O
equally	O
to	O
this	O
work	O
.	O

We	O
report	O
a	O
cholesterol	O
imaging	O
method	O
using	O
rationally	O
synthesized	O
phenyl	O
-	O
diyne	O
cholesterol	O
(	O
PhDY	O
-	O
Chol	O
)	O
and	O
stimulated	O
Raman	O
scattering	O
(	O
SRS	O
)	O
microscope	O
.	O

The	O
phenyl	O
-	O
diyne	O
group	O
is	O
biologically	O
inert	O
and	O
provides	O
a	O
Raman	O
scattering	O
cross	O
section	O
that	O
is	O
88	O
times	O
larger	O
than	O
the	O
endogenous	O
C	O
=	O
O	O
stretching	O
mode	O
.	O

SRS	O
microscopy	O
offers	O
an	O
imaging	O
speed	O
that	O
is	O
faster	O
than	O
spontaneous	O
Raman	O
microscopy	O
by	O
three	O
orders	O
of	O
magnitude	O
,	O
and	O
a	O
detection	O
sensitivity	O
of	O
31	O
μM	O
PhDY	O
-	O
Chol	O
(~	O
1	O
,	O
800	O
molecules	O
in	O
the	O
excitation	O
volume	O
).	O

Inside	O
living	O
CHO	O
cells	O
,	O
PhDY	O
-	O
Chol	O
mimics	O
the	O
behavior	O
of	O
cholesterol	O
,	O
including	O
membrane	O
incorporation	O
and	O
esterification	O
.	O

In	O
a	O
cellular	O
model	O
of	O
Niemann	B-DS
-	I-DS
Pick	I-DS
type	I-DS
C	I-DS
disease	I-DS
,	O
PhDY	O
-	O
Chol	O
reflects	O
the	O
lysosomal	O
accumulation	O
of	O
cholesterol	O
,	O
and	O
shows	O
relocation	O
to	O
lipid	O
droplets	O
after	O
HPβCD	O
treatment	O
.	O

In	O
live	O
C	B-OG
.	I-OG
elegans	I-OG
,	O
PhDY	O
-	O
Chol	O
mimics	O
cholesterol	O
uptake	O
by	O
intestinal	O
cells	O
and	O
reflects	O
cholesterol	O
storage	O
.	O

Together	O
,	O
our	O
work	O
demonstrates	O
an	O
enabling	O
platform	O
for	O
study	O
of	O
cholesterol	O
storage	O
and	O
trafficking	O
in	O
living	O
cells	O
and	O
vital	O
organisms	O
.	O

As	O
an	O
important	O
component	O
of	O
cellular	O
membrane	O
,	O
cholesterol	O
controls	O
physical	O
properties	O
of	O
the	O
membrane	O
and	O
contributes	O
to	O
specific	O
membrane	O
structures	O
such	O
as	O
lipid	O
rafts12	O
.	O

Inside	O
cells	O
,	O
cholesterol	O
plays	O
an	O
important	O
role	O
in	O
various	O
signaling	O
pathways34	O
and	O
serves	O
as	O
the	O
precursor	O
for	O
signaling	O
molecules	O
,	O
and	O
modifies	O
specific	O
proteins	O
,	O
such	O
as	O
hedgehog	B-GP
,	O
to	O
control	O
protein	O
trafficking	O
and	O
activity5	O
.	O

The	O
distribution	O
of	O
cholesterol	O
in	O
a	O
living	O
cell	O
is	O
highly	O
regulated67	O
.	O

Intracellular	O
cholesterol	O
is	O
stored	O
in	O
lipid	O
droplets	O
(	O
LDs	O
)	O
in	O
the	O
form	O
of	O
cholesteryl	O
ester	O
to	O
avoid	O
the	O
toxicity	O
caused	O
by	O
free	O
cholesterol89	O
.	O

Dysregulation	O
of	O
cholesterol	O
metabolism	O
and	O
/	O
or	O
trafficking	O
has	O
been	O
linked	O
to	O
diseases	O
,	O
including	O
atherosclerosis910	B-DS
,	O
Niemann	B-DS
-	I-DS
Pick	I-DS
type	I-DS
C	I-DS
(	I-DS
NP	I-DS
-	I-DS
C	I-DS
)	I-DS
disease11	I-DS
,	O
and	O
various	O
cancers1213	B-DS
.	O

So	O
far	O
,	O
our	O
understanding	O
of	O
cholesterol	O
transport	O
and	O
metabolism	O
is	O
limited	O
,	O
partly	O
due	O
to	O
lack	O
of	O
suitable	O
tools	O
for	O
imaging	O
cholesterol	O
in	O
a	O
living	O
system14	O
.	O

Intracellular	O
cholesterol	O
transport	O
and	O
metabolism	O
have	O
been	O
studied	O
extensively	O
using	O
various	O
reporter	O
molecules15	O
,	O
including	O
cholesterol	O
binding	O
molecules	O
and	O
cholesterol	O
analogs	O
.	O

Cholesterol	O
binding	O
molecules	O
,	O
such	O
as	O
cholesterol	B-GP
oxidase	I-GP
,	O
filipin	O
,	O
and	O
perfringolysin	B-GP
O	I-GP
derivatives	O
,	O
are	O
commonly	O
used	O
to	O
study	O
steady	O
-	O
state	O
distribution	O
of	O
cholesterol	O
in	O
fixed	O
cells	O
and	O
tissues161718	O
.	O

Fluorescent	O
cholesterol	O
,	O
including	O
intrinsic	O
fluorescent	O
sterols	O
such	O
as	O
dehydroergosterol	O
(	O
DHE	O
)	O
and	O
fluorophore	O
-	O
tagged	O
analogs	O
such	O
as	O
7	O
-	O
nitrobenz	O
-	O
2	O
-	O
oxa	O
-	O
1	O
,	O
3	O
-	O
diazole	O
(	O
NBD	O
)-	O
cholesterol	O
and	O
boron	O
dipyrromethene	O
difluoride	O
(	O
BODIPY	O
)-	O
cholesterol	O
are	O
widely	O
used	O
in	O
vitro	O
and	O
in	O
vivo192021	O
.	O

Radiolabeled	O
cholesterol	O
or	O
its	O
precursors	O
are	O
used	O
in	O
biochemical	O
studies	O
of	O
metabolism	O
and	O
trafficking	O
of	O
cholesterol15	O
.	O

More	O
recently	O
,	O
clickable	O
cholesterol	O
analogs	O
were	O
also	O
developed	O
for	O
studying	O
cholesterol	O
-	O
binding	O
proteins	O
and	O
tracking	O
cholesterol	O
metabolism	O
and	O
distribution2223	O
.	O

These	O
current	O
cholesterol	O
assays	O
have	O
limitations	O
.	O

Cholesterol	B-GP
oxidase	I-GP
is	O
commonly	O
used	O
in	O
fluorometric	O
or	O
colorimetric	O
assays	O
to	O
quantify	O
total	O
cholesterol	O
in	O
homogenized	O
cells	O
.	O

Radiolabeled	O
cholesterol	O
has	O
to	O
be	O
used	O
in	O
combination	O
with	O
separation	O
methods	O
to	O
determine	O
intracellular	O
cholesterol	O
distribution	O
indirectly	O
.	O

For	O
imaging	O
purpose	O
,	O
filipin	O
is	O
the	O
most	O
commonly	O
used	O
molecule	O
for	O
visualizing	O
distribution	O
of	O
free	O
cholesterol	O
,	O
but	O
it	O
is	O
only	O
applicable	O
to	O
fixed	O
cells	O
or	O
tissues	O
with	O
moderate	O
specificity	O
because	O
filipin	O
also	O
labels	O
other	O
lipids24	O
.	O

BODIPY	O
-	O
cholesterol	O
is	O
known	O
to	O
cause	O
perturbations	O
due	O
to	O
bulkiness	O
of	O
the	O
fluorophores25	O
.	O

DHE	O
has	O
the	O
closest	O
structure	O
as	O
cholesterol	O
,	O
but	O
its	O
fluorescence	O
undergoes	O
rapid	O
photo	O
-	O
bleaching15	O
,	O
which	O
impedes	O
real	O
-	O
time	O
observation	O
of	O
cholesterol	O
trafficking	O
.	O

Clickable	O
cholesterol	O
analog	O
requires	O
additional	O
steps	O
before	O
fluorescence	O
imaging	O
.	O

Owing	O
to	O
smaller	O
volumes	O
compared	O
to	O
fluorophores	O
,	O
Raman	O
tags	O
provide	O
a	O
promising	O
way	O
of	O
imaging	O
biomolecules	O
like	O
DNA	O
and	O
cytochrome	B-GP
c	I-GP
inside	O
cells	O
on	O
a	O
Raman	O
microscope2627	O
.	O

These	O
Raman	O
tags	O
utilize	O
the	O
vibrational	O
signatures	O
of	O
the	O
carbon	O
-	O
deuterium	O
(	O
C	O
–	O
D	O
)	O
bond	O
,	O
the	O
cyano	O
bond	O
(	O
C	O
≡	O
N	O
)	O
or	O
the	O
alkyne	O
bond	O
(	O
C	O
≡	O
C	O
)	O
that	O
are	O
spectrally	O
isolated	O
from	O
the	O
endogenous	O
Raman	O
bands28	O
.	O

Spontaneous	O
Raman	O
imaging	O
has	O
allowed	O
cellular	O
trafficking	O
of	O
different	O
C	O
–	O
D	O
labeled	O
lipid	O
species	O
in	O
fixed	O
cells29	O
,	O
and	O
direct	O
visualization	O
of	O
alkyne	O
-	O
tagged	O
DNA	O
synthesis	O
and	O
cytochrome	B-GP
c	I-GP
release	O
from	O
mitochondria	O
in	O
living	O
cells2627	O
with	O
an	O
image	O
acquisition	O
speed	O
of	O
50	O
min	O
per	O
frame	O
of	O
127	O
×	O
127	O
pixels	O
.	O

To	O
enhance	O
the	O
signal	O
level	O
,	O
nonlinear	O
vibrational	O
microscopy	O
based	O
on	O
the	O
coherent	O
Raman	O
process	O
has	O
been	O
developed30	O
and	O
deployed	O
for	O
imaging	O
C	O
–	O
D	O
labeled	O
fatty	O
acids3132	O
,	O
amino	O
acids33	O
,	O
and	O
drugs34	O
in	O
living	O
cells	O
with	O
a	O
speed	O
that	O
is	O
~	O
1	O
,	O
000	O
times	O
faster	O
than	O
with	O
spontaneous	O
Raman	O
microscopy	O
.	O

More	O
recently	O
,	O
stimulated	O
Raman	O
scattering	O
(	O
SRS	O
)	O
imaging	O
of	O
alkyne	O
-	O
tagged	O
molecules	O
has	O
been	O
reported	O
,	O
with	O
a	O
detection	O
limit	O
at	O
the	O
level	O
of	O
hundreds	O
of	O
micromolar3536	O
.	O

SRS	O
is	O
a	O
third	O
order	O
nonlinear	O
optical	O
process	O
that	O
involves	O
two	O
laser	O
fields	O
,	O
namely	O
,	O
a	O
pump	O
field	O
at	O
ωp	O
and	O
a	O
Stokes	O
field	O
at	O
ωS	O
.	O

When	O
the	O
beating	O
frequency	O
(	O
ωp	O
−	O
ωS	O
)	O
is	O
tuned	O
to	O
excite	O
a	O
molecular	O
vibration	O
,	O
the	O
energy	O
difference	O
between	O
ωp	O
and	O
ωS	O
pumps	O
the	O
molecule	O
from	O
a	O
ground	O
state	O
to	O
a	O
vibrationally	O
excited	O
state	O
.	O

In	O
correspondence	O
,	O
the	O
laser	O
fields	O
experience	O
a	O
weak	O
decrease	O
in	O
pump	O
beam	O
intensity	O
,	O
called	O
stimulated	O
Raman	O
loss	O
(	O
SRL	O
),	O
and	O
a	O
corresponding	O
increase	O
in	O
Stokes	O
beam	O
intensity	O
,	O
called	O
stimulated	O
Raman	O
gain	O
(	O
SRG	O
).	O

In	O
the	O
case	O
of	O
SRL	O
,	O
the	O
Stokes	O
beam	O
intensity	O
IS	O
is	O
modulated	O
and	O
the	O
pump	O
beam	O
intensity	O
Ip	O
is	O
recorded	O
by	O
a	O
photodiode	O
.	O

The	O
induced	O
modulation	O
is	O
often	O
extracted	O
by	O
a	O
lock	O
-	O
in	O
amplifier	O
.	O

Theoretically	O
,	O
the	O
modulation	O
depth	O
induced	O
by	O
SRL	O
,	O
ISRL	O
/	O
Ip	O
,	O
is	O
linearly	O
proportional	O
to	O
the	O
Raman	O
cross	O
section	O
,	O
σ	O
,	O
molar	O
concentration	O
of	O
the	O
target	O
molecule	O
,	O
N	O
,	O
and	O
the	O
Stokes	O
beam	O
intensity	O
,	O
i	O
.	O
e	O
.,	O
ISRL	O
/	O
Ip	O
∝	O
σ	O
N	O
IS	O
.	O

SRS	O
microscopy	O
offers	O
much	O
faster	O
imaging	O
speed	O
compared	O
to	O
spontaneous	O
Raman	O
microscopy37	O
.	O

Here	O
,	O
we	O
report	O
the	O
synthesis	O
of	O
a	O
Raman	O
probe	O
,	O
phenyl	O
-	O
diyne	O
cholesterol	O
(	O
PhDY	O
-	O
Chol	O
),	O
and	O
its	O
use	O
for	O
imaging	O
cholesterol	O
esterification	O
,	O
storage	O
and	O
trafficking	O
inside	O
living	O
cells	O
and	O
vital	O
organisms	O
.	O

By	O
rational	O
design	O
and	O
chemical	O
synthesis	O
,	O
we	O
prepared	O
a	O
probe	O
molecule	O
,	O
PhDY	O
-	O
Chol	O
,	O
which	O
gives	O
a	O
2	O
,	O
254	O
cm	O
−	O
1	O
Raman	O
peak	O
that	O
is	O
88	O
times	O
stronger	O
than	O
the	O
endogenous	O
C	O
=	O
O	O
stretching	O
band	O
.	O

Compared	O
to	O
alkyne	O
-	O
tagged	O
cholesterol	O
of	O
which	O
the	O
IC50	O
is	O
16	O
μM	O
,	O
the	O
phenyl	O
-	O
diyne	O
group	O
is	O
biologically	O
inert	O
and	O
did	O
not	O
cause	O
cytotoxicity	O
after	O
16	O
h	O
incubation	O
at	O
50	O
μM	O
.	O

In	O
live	O
Chinese	B-OG
hamster	I-OG
ovary	O
(	O
CHO	O
)	O
cells	O
,	O
SRS	O
imaging	O
showed	O
incorporation	O
into	O
plasma	O
membrane	O
,	O
esterification	O
of	O
PhDY	O
-	O
Chol	O
by	O
acyl	B-GP
-	I-GP
CoA	I-GP
:	I-GP
cholesterol	I-GP
acyltransferase	I-GP
1	I-GP
(	O
ACAT	B-GP
-	I-GP
1	I-GP
),	O
and	O
storage	O
in	O
LDs	O
.	O

In	O
a	O
cellular	O
model	O
of	O
NP	B-DS
-	I-DS
C	I-DS
disease	I-DS
,	O
PhDY	O
-	O
Chol	O
is	O
selectively	O
accumulated	O
in	O
lysosomes	O
and	O
is	O
esterified	O
and	O
relocated	O
to	O
LDs	O
after	O
treatment	O
with	O
a	O
cholesterol	O
-	O
mobilization	O
drug	O
.	O

In	O
live	O
C	B-OG
.	I-OG
elegans	I-OG
,	O
SRS	O
imaging	O
of	O
PhDY	O
-	O
Chol	O
reflected	O
cholesterol	O
uptake	O
through	O
ChUP	B-GP
-	I-GP
1	I-GP
regulated	O
manner	O
,	O
and	O
storage	O
in	O
the	O
intestinal	O
cells	O
.	O

These	O
studies	O
herald	O
the	O
potential	O
of	O
our	O
method	O
for	O
unveiling	O
intracellular	O
cholesterol	O
trafficking	O
mechanisms	O
and	O
highly	O
efficient	O
screening	O
of	O
drugs	O
that	O
target	O
cholesterol	O
metabolism	O
.	O

Results	O

Rational	O
design	O
and	O
synthesis	O
of	O
tagged	O
cholesterol	O
with	O
an	O
extremely	O
large	O
Raman	O
scattering	O
cross	O
section	O

In	O
order	O
to	O
design	O
a	O
probe	O
molecule	O
that	O
not	O
only	O
maintains	O
physiological	O
functions	O
of	O
cholesterol	O
,	O
but	O
also	O
has	O
a	O
large	O
Raman	O
scattering	O
cross	O
section	O
,	O
we	O
chose	O
to	O
replace	O
the	O
aliphatic	O
side	O
chain	O
of	O
cholesterol	O
with	O
a	O
cyano	O
or	O
an	O
alkynyl	O
group	O
(	O
Fig	O
.	O
1	O
).	O

These	O
groups	O
have	O
small	O
size	O
,	O
which	O
could	O
minimize	O
structural	O
perturbation	O
of	O
the	O
molecule	O
of	O
interest	O
,	O
in	O
this	O
case	O
,	O
cholesterol	O
.	O

Meanwhile	O
,	O
these	O
groups	O
produce	O
strong	O
Raman	O
scattering	O
peaks	O
in	O
a	O
cellular	O
silent	O
region	O
(	O
1	O
,	O
800	O
–	O
2	O
,	O
800	O
cm	O
−	O
1	O
)	O
2628	O
and	O
therefore	O
,	O
can	O
potentially	O
be	O
used	O
for	O
Raman	O
imaging	O
in	O
a	O
low	O
-	O
concentration	O
condition	O
.	O

It	O
has	O
been	O
reported	O
that	O
as	O
the	O
chain	O
length	O
increases	O
,	O
the	O
hyperpolarizability	O
increases	O
in	O
polyynes38	O
.	O

Also	O
,	O
aromatic	O
ring	O
capped	O
alkyne	O
was	O
shown	O
to	O
give	O
stronger	O
Raman	O
signals	O
than	O
terminal	O
alkyne27	O
.	O

To	O
design	O
tagged	O
cholesterol	O
with	O
very	O
strong	O
Raman	O
intensity	O
,	O
we	O
calculated	O
the	O
Raman	O
cross	O
section	O
of	O
potential	O
tags	O
,	O
namely	O
alkyne	O
,	O
phenyl	O
-	O
alkyne	O
,	O
diyne	O
,	O
and	O
phenyl	O
-	O
diyne	O
,	O
using	O
the	O
Q	O
-	O
Chem	O
and	O
GAMESS	O
electronic	O
structure	O
packages	O
to	O
provide	O
insight	O
of	O
the	O
relation	O
between	O
molecular	O
structure	O
and	O
Raman	O
intensity	O
.	O

Our	O
results	O
show	O
that	O
the	O
localized	O
polarizabilities	O
on	O
each	O
C	O
≡	O
C	O
moiety	O
increase	O
with	O
the	O
number	O
of	O
conjugated	O
triple	O
bonds	O
,	O
as	O
well	O
as	O
with	O
addition	O
of	O
a	O
phenyl	O
ring	O
(	O
Supplementary	O
Figure	O
1a	O
and	O
Supplementary	O
Table	O
1	O
).	O

Thus	O
,	O
the	O
total	O
polarizability	O
of	O
the	O
molecule	O
increases	O
as	O
a	O
result	O
of	O
the	O
additive	O
effect	O
as	O
well	O
as	O
non	O
-	O
linear	O
boost	O
in	O
the	O
polarizability	O
of	O
conjugated	O
bonds	O
.	O

The	O
phenyl	O
ring	O
serves	O
as	O
both	O
a	O
donor	O
and	O
an	O
acceptor	O
of	O
π	O
-	O
electrons	O
from	O
the	O
neighboring	O
triple	O
bonds	O
,	O
further	O
escalating	O
polarizabilities	O
of	O
neighboring	O
conjugated	O
bonds	O
.	O

Taking	O
into	O
account	O
that	O
the	O
Raman	O
intensity	O
is	O
proportional	O
to	O
squares	O
of	O
polarizability	O
derivatives	O
,	O
the	O
additional	O
three	O
-	O
fold	O
enhancement	O
of	O
the	O
total	O
polarizability	O
due	O
to	O
conjugation	O
results	O
in	O
a	O
~	O
10	O
-	O
fold	O
boost	O
in	O
Raman	O
intensity	O
.	O

Together	O
,	O
compared	O
to	O
the	O
alkyne	O
group	O
,	O
the	O
Raman	O
intensity	O
increases	O
by	O
9	O
times	O
by	O
adding	O
a	O
phenyl	O
group	O
to	O
the	O
terminal	O
alkyne	O
,	O
and	O
52	O
times	O
by	O
conjugating	O
a	O
phenyl	O
group	O
and	O
another	O
alkyne	O
(	O
Supplementary	O
Fig	O
.	O
1b	O
).	O

Based	O
on	O
the	O
above	O
considerations	O
,	O
we	O
have	O
synthesized	O
a	O
series	O
of	O
tagged	O
cholesterols	O
–	O
alkyne	O
cholesterol	O
(	O
A	O
-	O
Chol	O
,	O
5	O
),	O
phenyl	O
-	O
alkyne	O
cholesterol	O
(	O
PhA	O
-	O
Chol	O
,	O
6	O
),	O
phenyl	O
-	O
diyne	O
cholesterol	O
(	O
PhDY	O
-	O
Chol	O
,	O
7	O
),	O
and	O
cyano	O
cholesterol	O
(	O
CN	O
-	O
Chol	O
,	O
8	O
),	O
as	O
shown	O
in	O
Figure	O
1	O
.	O

Our	O
synthesis	O
commenced	O
with	O
commercially	O
available	O
cholenic	O
acid	O
3	O
.	O

Using	O
a	O
sequence	O
of	O
THP	O
-	O
protection	O
,	O
LiAlH4	O
reduction	O
,	O
Dess	O
-	O
Martin	O
oxidation	O
and	O
Seyferth	O
-	O
Gilbert	O
-	O
Bestmann	O
homologation	O
,	O
cholenic	O
acid	O
3	O
was	O
converted	O
to	O
compound	O
4	O
with	O
a	O
terminal	O
alkyne	O
group	O
in	O
excellent	O
yield	O
.	O

Removal	O
of	O
the	O
THP	O
-	O
protecting	O
group	O
gave	O
probe	O
5	O
.	O

We	O
further	O
prepared	O
PhA	O
-	O
Chol	O
6	O
and	O
PhDY	O
-	O
Chol	O
7	O
from	O
compound	O
4	O
via	O
a	O
palladium	O
-	O
catalyzed	O
Sonogashira	O
reaction	O
and	O
a	O
copper	O
-	O
catalyzed	O
Cadiot	O
-	O
Chodkiewicz	O
reaction	O
,	O
respectively	O
,	O
followed	O
by	O
acidic	O
removal	O
of	O
THP	O
group	O
.	O

Additionally	O
,	O
CN	O
-	O
Chol	O
8	O
was	O
prepared	O
from	O
cholenic	O
acid	O
3	O
via	O
standard	O
transformations	O
.	O

Raman	O
spectral	O
analysis	O
and	O
SRS	O
imaging	O
of	O
tagged	O
cholesterol	O

To	O
determine	O
the	O
Raman	O
shift	O
of	O
the	O
C	O
≡	O
C	O
stretching	O
vibrational	O
mode	O
and	O
to	O
compare	O
the	O
level	O
of	O
Raman	O
signals	O
from	O
the	O
tagged	O
cholesterols	O
,	O
we	O
prepared	O
50	O
mM	O
of	O
each	O
compound	O
in	O
cyclohexanone	O
and	O
performed	O
confocal	O
Raman	O
spectral	O
analysis	O
(	O
Fig	O
.	O
2	O
).	O

The	O
signal	O
from	O
CN	O
-	O
Chol	O
was	O
too	O
weak	O
to	O
be	O
detected	O
.	O

A	O
-	O
Chol	O
showed	O
its	O
peak	O
for	O
C	O
≡	O
C	O
vibrational	O
mode	O
at	O
2	O
,	O
122	O
cm	O
−	O
1	O
;	O
PhA	O
-	O
Chol	O
at	O
2	O
,	O
239	O
cm	O
−	O
1	O
;	O
PhDY	O
-	O
Chol	O
at	O
2	O
,	O
254	O
cm	O
−	O
1	O
(	O
Fig	O
.	O
2a	O
).	O

To	O
evaluate	O
the	O
amplitude	O
of	O
the	O
Raman	O
scattering	O
cross	O
section	O
,	O
we	O
fitted	O
each	O
Raman	O
band	O
with	O
a	O
Lorentzian	O
profile	O
and	O
calculated	O
the	O
area	O
under	O
the	O
fitted	O
profile	O
.	O

Compared	O
to	O
the	O
Raman	O
peak	O
of	O
each	O
tag	O
to	O
the	O
1	O
,	O
714	O
cm	O
−	O
1	O
C	O
=	O
O	O
Raman	O
peak	O
from	O
the	O
solvent	O
(	O
9	O
.	O
7	O
M	O
for	O
pure	O
cyclohexanone	O
),	O
the	O
alkyne	O
,	O
PhA	O
,	O
and	O
PhDY	O
groups	O
were	O
found	O
to	O
be	O
6	O
,	O
15	O
,	O
and	O
88	O
times	O
stronger	O
in	O
Raman	O
cross	O
section	O
,	O
respectively	O
(	O
Fig	O
.	O
2b	O
).	O

This	O
result	O
showed	O
that	O
the	O
PhDY	O
tag	O
produces	O
a	O
spectrally	O
-	O
isolated	O
peak	O
,	O
which	O
is	O
stronger	O
than	O
the	O
C	O
=	O
O	O
vibrational	O
mode	O
by	O
two	O
orders	O
of	O
magnitude	O
.	O

To	O
determine	O
the	O
SRS	O
imaging	O
sensitivity	O
for	O
PhDY	O
-	O
Chol	O
,	O
we	O
used	O
a	O
femtosecond	O
SRL	O
microscope	O
reported	O
elsewhere32	O
.	O

Cyclohexanone	O
solutions	O
of	O
PhDY	O
-	O
Chol	O
were	O
prepared	O
by	O
serial	O
dilution	O
,	O
and	O
SRS	O
images	O
of	O
PhDY	O
-	O
Chol	O
were	O
recorded	O
with	O
the	O
laser	O
beating	O
frequency	O
tuned	O
to	O
be	O
resonant	O
with	O
C	O
≡	O
C	O
vibration	O
at	O
2	O
,	O
254	O
cm	O
−	O
1	O
.	O

In	O
solutions	O
without	O
PhDY	O
-	O
Chol	O
,	O
a	O
residual	O
background	O
was	O
detected	O
,	O
caused	O
by	O
cross	O
phase	O
modulation	O
.	O

The	O
SRS	O
contrast	O
,	O
defined	O
as	O
(	O
S	O
−	O
B	O
)/	O
B	O
,	O
where	O
S	O
and	O
B	O
denote	O
SRS	O
signal	O
and	O
background	O
,	O
was	O
calculated	O
as	O
a	O
function	O
of	O
PhDY	O
-	O
Chol	O
molar	O
concentration	O
.	O

At	O
the	O
speed	O
of	O
200	O
μs	O
per	O
pixel	O
,	O
a	O
linear	O
relationship	O
was	O
observed	O
(	O
Fig	O
.	O
2c	O
)	O
and	O
13	O
%	O
and	O
4	O
%	O
contrasts	O
were	O
reached	O
at	O
313	O
μM	O
and	O
156	O
μM	O
,	O
respectively	O
.	O

To	O
increase	O
the	O
detection	O
sensitivity	O
,	O
we	O
chirped	O
the	O
femtosecond	O
lasers	O
to	O
0	O
.	O
8	O
picoseconds	O
with	O
a	O
SF	O
-	O
10	O
glass	O
rod	O
.	O

This	O
spectral	O
focusing	O
approach39	O
maintained	O
85	O
%	O
of	O
the	O
SRS	O
signal	O
while	O
reduced	O
the	O
cross	O
phase	O
modulation	O
background	O
level	O
by	O
3	O
times	O
,	O
to	O
a	O
level	O
of	O
6	O
.	O
3	O
×	O
10	O
−	O
7	O
in	O
terms	O
of	O
modulation	O
depth	O
.	O

As	O
a	O
result	O
,	O
the	O
SRS	O
contrast	O
became	O
14	O
%	O
at	O
31	O
μM	O
,	O
corresponding	O
to	O
~	O
1	O
,	O
800	O
molecules	O
in	O
the	O
excitation	O
volume	O
(	O
Fig	O
.	O
2d	O
).	O

We	O
also	O
depicted	O
the	O
modulation	O
depth	O
(	O
ΔI	O
/	O
I	O
)	O
as	O
a	O
function	O
of	O
molar	O
concentration	O
(	O
Supplementary	O
Fig	O
.	O
2	O
),	O
which	O
is	O
used	O
for	O
estimating	O
the	O
molar	O
concentration	O
of	O
PhDY	O
-	O
Chol	O
inside	O
cells	O
in	O
following	O
studies	O
.	O

Cytotoxicity	O
caused	O
by	O
terminal	O
alkyne	O
is	O
avoided	O
by	O
phenyl	O
group	O

To	O
evaluate	O
the	O
cytotoxicity	O
of	O
tagged	O
cholesterols	O
,	O
we	O
performed	O
MTT	O
cell	O
-	O
viability	O
assays	O
after	O
treating	O
CHO	O
cells	O
with	O
tagged	O
cholesterol	O
.	O

Various	O
concentrations	O
of	O
tagged	O
cholesterol	O
were	O
added	O
to	O
the	O
culture	O
media	O
and	O
the	O
cells	O
were	O
incubated	O
for	O
48	O
h	O
before	O
the	O
assays	O
were	O
conducted	O
.	O

A	O
-	O
Chol	O
was	O
found	O
to	O
be	O
toxic	O
to	O
the	O
cells	O
with	O
IC50	O
of	O
16	O
μM	O
.	O

Importantly	O
,	O
adding	O
a	O
phenyl	O
group	O
effectively	O
reduced	O
the	O
cytotoxicity	O
(	O
Supplementary	O
Fig	O
.	O
3a	O
).	O

To	O
directly	O
visualize	O
the	O
toxic	O
effect	O
,	O
we	O
stained	O
the	O
cells	O
with	O
propidium	O
iodide	O
for	O
late	O
apoptosis	O
and	O
necrosis	O
.	O

Cells	O
incubated	O
with	O
A	O
-	O
Chol	O
showed	O
reduced	O
density	O
and	O
extensive	O
apoptosis	O
,	O
whereas	O
both	O
PhA	O
-	O
Chol	O
and	O
PhDY	O
-	O
Chol	O
caused	O
minimum	O
cell	O
death	O
(	O
Supplementary	O
Fig	O
.	O
3b	O
).	O

This	O
result	O
presents	O
another	O
important	O
role	O
of	O
the	O
phenyl	O
group	O
,	O
which	O
is	O
to	O
reduce	O
the	O
toxicity	O
caused	O
by	O
terminal	O
alkyne	O
.	O

Based	O
on	O
the	O
signal	O
level	O
and	O
the	O
severity	O
of	O
toxicity	O
,	O
we	O
conclude	O
that	O
PhDY	O
-	O
Chol	O
is	O
the	O
most	O
suitable	O
cholesterol	O
analog	O
for	O
live	O
cell	O
imaging	O
,	O
and	O
we	O
used	O
PhDY	O
-	O
Chol	O
in	O
subsequent	O
experiments	O
.	O

Membrane	O
incorporation	O
and	O
esterification	O
of	O
PhDY	O
-	O
Chol	O
in	O
live	O
cells	O

We	O
chose	O
CHO	O
cells	O
which	O
are	O
commonly	O
used	O
for	O
cholesterol	O
trafficking	O
and	O
metabolism	O
studies40	O
.	O

To	O
enhance	O
cellular	O
uptake	O
of	O
PhDY	O
-	O
Chol	O
,	O
the	O
cells	O
were	O
pre	O
-	O
incubated	O
in	O
medium	O
supplemented	O
with	O
lipoprotein	O
-	O
deficient	O
serum	O
to	O
deplete	O
medium	O
cholesterol	O
,	O
after	O
which	O
the	O
cells	O
were	O
incubated	O
with	O
50	O
μM	O
PhDY	O
-	O
Chol	O
for	O
16	O
h	O
.	O

By	O
tuning	O
the	O
laser	O
beating	O
frequency	O
to	O
be	O
resonant	O
with	O
C	O
≡	O
C	O
vibration	O
(	O
2	O
,	O
254	O
cm	O
−	O
1	O
),	O
SRL	O
signals	O
arose	O
from	O
PhDY	O
-	O
Chol	O
.	O

We	O
also	O
tuned	O
the	O
laser	O
to	O
be	O
resonant	O
with	O
C	O
–	O
H	O
vibration	O
(	O
2	O
,	O
885	O
cm	O
−	O
1	O
)	O
and	O
obtained	O
signals	O
from	O
C	O
–	O
H	O
-	O
rich	O
lipid	O
structures	O
,	O
such	O
as	O
LDs	O
.	O

To	O
show	O
the	O
incorporation	O
of	O
PhDY	O
-	O
Chol	O
into	O
the	O
plasma	O
membrane	O
,	O
we	O
performed	O
spectral	O
focusing	O
SRS	O
imaging	O
of	O
live	O
CHO	O
cells	O
after	O
treating	O
with	O
PhDY	O
-	O
Chol	O
for	O
1	O
h	O
with	O
6	O
μs	O
per	O
pixel	O
speed	O
.	O

PhDY	O
-	O
Chol	O
in	O
the	O
membrane	O
was	O
detected	O
in	O
the	O
on	O
-	O
resonance	O
image	O
,	O
and	O
the	O
contrast	O
disappeared	O
in	O
the	O
off	O
-	O
resonance	O
image	O
(	O
Supplementary	O
Fig	O
.	O
4a	O
).	O

The	O
membrane	O
incorporation	O
was	O
confirmed	O
by	O
filipin	O
staining	O
of	O
free	O
cholesterol	O
and	O
Raman	O
spectral	O
analysis	O
(	O
Supplementary	O
Fig	O
.	O
4b	O
and	O
4c	O
).	O

By	O
focusing	O
at	O
the	O
filipin	O
-	O
stained	O
membrane	O
,	O
we	O
have	O
obtained	O
the	O
Raman	O
spectrum	O
showing	O
the	O
C	O
=	O
C	O
band	O
from	O
filipin	O
(	O
Supplementary	O
Fig	O
.	O
4d	O
),	O
the	O
amide	O
I	O
band	O
from	O
protein	O
,	O
and	O
the	O
C	O
≡	O
C	O
band	O
from	O
the	O
PhDY	O
(	O
Supplementary	O
Fig	O
.	O
4c	O
).	O

Inside	O
live	O
CHO	O
cells	O
,	O
PhDY	O
-	O
Chol	O
was	O
colocalized	O
with	O
LDs	O
found	O
in	O
the	O
C	O
–	O
H	O
vibrational	O
region	O
(	O
Fig	O
.	O
3a	O
).	O

This	O
colocalization	O
was	O
confirmed	O
by	O
two	O
-	O
photon	O
-	O
excited	O
fluorescence	O
(	O
TPEF	O
)	O
imaging	O
and	O
Raman	O
spectral	O
analysis	O
of	O
BODIPY	O
-	O
stained	O
LDs	O
in	O
fixed	O
CHO	O
cells	O
.	O

(	O
Supplementary	O
Fig	O
.	O
5a	O
and	O
5b	O
).	O

The	O
Raman	O
spectra	O
of	O
the	O
BODIPY	O
-	O
labeled	O
LDs	O
showed	O
702	O
cm	O
−	O
1	O
peak	O
from	O
cholesterol	O
ring	O
and	O
the	O
C	O
≡	O
C	O
band	O
from	O
the	O
PhDY	O
(	O
Supplementary	O
Fig	O
.	O
5b	O
),	O
which	O
further	O
supports	O
the	O
localization	O
of	O
PhDY	O
-	O
Chol	O
in	O
LDs	O
.	O

Importantly	O
,	O
high	O
imaging	O
speed	O
offered	O
by	O
SRS	O
microscopy	O
allowed	O
real	O
-	O
time	O
imaging	O
of	O
the	O
trafficking	O
of	O
PhDY	O
-	O
Chol	O
containing	O
LDs	O
within	O
living	O
cells	O
(	O
Supplementary	O
Movie	O
1	O
).	O

It	O
is	O
important	O
to	O
note	O
that	O
PhDY	O
-	O
Chol	O
-	O
rich	O
structures	O
inside	O
the	O
CHO	O
cells	O
could	O
not	O
be	O
stained	O
by	O
filipin	O
(	O
Supplementary	O
Fig	O
.	O
4b	O
),	O
implicating	O
that	O
it	O
is	O
not	O
in	O
the	O
free	O
form	O
.	O

We	O
hypothesize	O
that	O
PhDY	O
-	O
Chol	O
is	O
converted	O
into	O
PhDY	O
-	O
cholesteryl	O
ester	O
,	O
by	O
ACAT	B-GP
-	I-GP
1	I-GP
,	O
the	O
enzyme	O
responsible	O
for	O
cholesterol	O
esterification8	O
(	O
Fig	O
.	O
3b	O
).	O

To	O
confirm	O
the	O
esterification	O
of	O
PhDY	O
-	O
Chol	O
,	O
we	O
inhibited	O
ACAT	B-GP
with	O
avasimibe	O
for	O
24	O
h	O
before	O
addition	O
of	O
PhDY	O
-	O
Chol	O
.	O

After	O
blocking	O
cholesterol	O
esterification	O
,	O
the	O
amount	O
of	O
PhDY	O
-	O
Chol	O
storage	O
found	O
in	O
CHO	O
cells	O
significantly	O
decreased	O
(	O
Fig	O
.	O
3c	O
).	O

Although	O
LDs	O
were	O
still	O
visible	O
,	O
the	O
amount	O
of	O
PhDY	O
-	O
Chol	O
signal	O
found	O
inside	O
LDs	O
reduced	O
by	O
4	O
times	O
(	O
Fig	O
.	O
3d	O
).	O

ACAT	B-GP
-	I-GP
1	I-GP
knockdown	O
by	O
shRNA	O
was	O
also	O
conducted	O
to	O
specifically	O
inhibit	O
the	O
enzyme	O
.	O

Similarly	O
,	O
we	O
found	O
decreased	O
amount	O
of	O
PhDY	O
-	O
Chol	O
in	O
ACAT	B-GP
-	I-GP
1	I-GP
knocked	O
down	O
CHO	O
cells	O
,	O
and	O
the	O
amount	O
of	O
PhDY	O
-	O
Chol	O
in	O
LDs	O
reduced	O
significantly	O
(	O
Supplementary	O
Fig	O
.	O
6a	O
).	O

To	O
determine	O
where	O
PhDY	O
-	O
Chol	O
accumulates	O
after	O
ACAT	B-GP
-	I-GP
1	I-GP
inhibition	O
,	O
we	O
stained	O
the	O
cells	O
with	O
LysoTracker	O
for	O
lysosomes	O
.	O

Our	O
result	O
indicated	O
that	O
after	O
ACAT	B-GP
-	I-GP
1	I-GP
inhibition	O
,	O
PhDY	O
-	O
Chol	O
partially	O
located	O
in	O
lysosomes	O
(	O
Supplementary	O
Fig	O
.	O
6b	O
).	O

Collectively	O
,	O
these	O
results	O
show	O
that	O
PhDY	O
-	O
Chol	O
can	O
be	O
transported	O
into	O
cells	O
,	O
converted	O
into	O
PhDY	O
-	O
cholesteryl	O
ester	O
by	O
ACAT	B-GP
-	I-GP
1	I-GP
,	O
and	O
stored	O
in	O
LDs	O
following	O
the	O
normal	O
metabolic	O
pathway	O
of	O
cholesterol	O
.	O

To	O
emphasize	O
the	O
physiological	O
compatibility	O
of	O
our	O
PhDY	O
tag	O
,	O
we	O
treated	O
CHO	O
cells	O
with	O
BODIPY	O
-	O
cholesterol	O
.	O

The	O
amount	O
of	O
BODIPY	O
-	O
cholesterol	O
incorporated	O
into	O
LDs	O
did	O
not	O
change	O
after	O
ACAT	B-GP
-	I-GP
1	I-GP
inhibition	O
(	O
Fig	O
.	O
3d	O
and	O
3e	O
),	O
indicating	O
that	O
BODIPY	O
-	O
cholesterol	O
directly	O
labels	O
the	O
LDs	O
without	O
metabolic	O
conversion	O
into	O
cholesteryl	O
ester	O
.	O

It	O
is	O
known	O
that	O
excess	O
cholesterol	O
inside	O
cells	O
is	O
stored	O
into	O
LDs	O
through	O
cholesterol	O
esterification	O
by	O
ACAT	B-GP
proteins8	O
.	O

Therefore	O
,	O
PhDY	O
-	O
Chol	O
reflects	O
the	O
intracellular	O
cholesterol	O
metabolism	O
more	O
faithfully	O
compared	O
to	O
BODIPY	O
-	O
cholesterol	O
.	O

Lysosomal	O
accumulation	O
and	O
relocation	O
to	O
LDs	O
in	O
NP	B-DS
-	I-DS
C	I-DS
disease	I-DS
model	O

Next	O
,	O
we	O
explored	O
the	O
potential	O
of	O
PhDY	O
-	O
Chol	O
for	O
studying	O
cholesterol	O
transport	O
in	O
NP	B-DS
-	I-DS
C	I-DS
disease	I-DS
,	O
a	O
disorder	O
featured	O
by	O
abnormal	O
cholesterol	O
accumulation	O
in	O
late	O
endosome	O
/	O
lysosome	O
caused	O
by	O
mutation	O
in	O
NPC1	B-GP
or	O
2	O
gene41	O
.	O

M12	O
cells	O
,	O
mutant	O
CHO	O
cells	O
that	O
contain	O
a	O
deletion	O
of	O
the	O
NPC1	B-GP
locus	O
,	O
were	O
established	O
as	O
a	O
cellular	O
model	O
of	O
the	O
NP	O
-	O
C	O
disease42	O
.	O

By	O
combining	O
SRL	O
imaging	O
of	O
PhDY	O
with	O
TPEF	O
imaging	O
of	O
filipin	O
,	O
we	O
observed	O
that	O
,	O
unlike	O
wildtype	O
CHO	O
cells	O
,	O
the	O
PhDY	O
-	O
Chol	O
-	O
rich	O
structures	O
were	O
stained	O
by	O
filipin	O
,	O
indicating	O
that	O
these	O
PhDY	O
-	O
Chol	O
molecules	O
were	O
located	O
in	O
lysosomes	O
.	O

(	O
Fig	O
.	O
4a	O
,	O
Supplementary	O
Fig	O
.	O
7a	O
and	O
7b	O
).	O

Moreover	O
,	O
we	O
observed	O
some	O
filipin	O
labeled	O
structures	O
that	O
do	O
not	O
contain	O
PhDY	O
-	O
Chol	O
.	O

This	O
result	O
is	O
reasonable	O
given	O
that	O
filipin	O
has	O
been	O
shown	O
to	O
label	O
other	O
lipid	O
molecules	O
,	O
such	O
as	O
glycosphingolipids24	O
.	O

As	O
additional	O
evidence	O
,	O
we	O
incubated	O
M12	O
cells	O
with	O
PhDY	O
-	O
Chol	O
and	O
stained	O
the	O
cells	O
with	O
LysoTracker	O
.	O

It	O
was	O
found	O
that	O
all	O
PhDY	O
-	O
Chol	O
-	O
rich	O
areas	O
were	O
localized	O
in	O
LysoTracker	O
-	O
stained	O
organelles	O
(	O
Supplementary	O
Fig	O
.	O
7c	O
).	O

Collectively	O
,	O
these	O
results	O
showed	O
that	O
PhDY	O
-	O
Chol	O
selectively	O
represents	O
the	O
lysosomal	O
storage	O
of	O
cholesterol	O
in	O
the	O
NP	B-DS
-	I-DS
C	I-DS
disease	I-DS
model	O
.	O

We	O
then	O
treated	O
the	O
PhDY	O
-	O
Chol	O
-	O
labeled	O
M12	O
cells	O
with	O
a	O
cholesterol	O
-	O
mobilizing	O
drug	O
,	O
hydroxypropyl	O
β	O
-	O
cyclodextrin	O
(	O
HPβCD	O
)	O
43	O
.	O

This	O
drug	O
is	O
known	O
to	O
mediate	O
lysosomal	O
escape	O
of	O
cholesterol	O
,	O
and	O
promote	O
storage	O
of	O
excess	O
cholesterol	O
into	O
LDs44	O
.	O

After	O
treating	O
with	O
HPβCD	O
,	O
the	O
amount	O
of	O
PhDY	O
-	O
Chol	O
in	O
M12	O
cells	O
decreased	O
by	O
half	O
(	O
Fig	O
.	O
4b	O
and	O
c	O
).	O

Interestingly	O
,	O
we	O
observed	O
that	O
some	O
PhDY	O
-	O
Chol	O
-	O
rich	O
areas	O
were	O
not	O
labeled	O
by	O
filipin	O
after	O
HPβCD	O
treatment	O
(	O
arrow	O
heads	O
in	O
Fig	O
.	O
4b	O
).	O

These	O
areas	O
likely	O
represent	O
PhDY	O
-	O
cholesteryl	O
ester	O
stored	O
in	O
LDs	O
.	O

To	O
confirm	O
this	O
possibility	O
,	O
we	O
stained	O
the	O
cells	O
with	O
BODIPY	O
for	O
localization	O
of	O
LDs	O
.	O

The	O
result	O
clearly	O
showed	O
that	O
PhDY	O
-	O
Chol	O
has	O
moved	O
into	O
LDs	O
after	O
HPβCD	O
treatment	O
,	O
and	O
the	O
number	O
of	O
PhDY	O
-	O
rich	O
LDs	O
increased	O
significantly	O
(	O
Fig	O
.	O
4d	O
and	O
4e	O
).	O

Together	O
,	O
these	O
data	O
indicate	O
that	O
PhDY	O
-	O
Chol	O
can	O
be	O
used	O
as	O
a	O
reliable	O
cholesterol	O
analog	O
to	O
study	O
cholesterol	O
mobilization	O
inside	O
living	O
cells	O
.	O

Cholesterol	O
uptake	O
and	O
storage	O
in	O
intestinal	O
cells	O
in	O
C	B-OG
.	I-OG
elegans	I-OG
visualized	O
by	O
PhDY	O
-	O
Chol	O

Finally	O
,	O
to	O
demonstrate	O
the	O
capability	O
of	O
monitoring	O
cholesterol	O
uptake	O
and	O
distribution	O
in	O
vivo	O
,	O
we	O
used	O
C	B-OG
.	I-OG
elegans	I-OG
as	O
an	O
animal	B-OG
model	O
to	O
study	O
cholesterol	O
uptake	O
and	O
storage	O
.	O

We	O
fed	O
N2	O
wildtype	O
C	B-OG
.	I-OG
elegans	I-OG
with	O
PhDY	O
-	O
Chol	O
-	O
labeled	O
E	B-OG
.	I-OG
coli	I-OG
and	O
imaged	O
PhDY	O
-	O
Chol	O
storage	O
in	O
the	O
worms	O
using	O
our	O
SRL	O
microscope	O
at	O
speed	O
of	O
40	O
μs	O
per	O
pixel	O
.	O

PhDY	O
-	O
Chol	O
was	O
found	O
most	O
abundantly	O
in	O
the	O
intestinal	O
cells	O
inside	O
the	O
wildtype	O
worms	O
(	O
upper	O
panels	O
in	O
Fig	O
.	O
5a	O
).	O

To	O
confirm	O
the	O
uptake	O
of	O
PhDY	O
-	O
Chol	O
by	O
intestinal	O
cells	O
,	O
we	O
fed	O
ChUP	B-GP
-	I-GP
1	I-GP
mutant	O
C	B-OG
.	I-OG
elegans	I-OG
,	O
in	O
which	O
dietary	O
cholesterol	O
uptake	O
is	O
inhibited	O
by	O
ChUP	B-GP
-	I-GP
1	I-GP
deletion45	O
,	O
with	O
PhDY	O
-	O
Chol	O
.	O

We	O
did	O
not	O
observe	O
PhDY	O
-	O
Chol	O
inside	O
this	O
strain	O
(	O
lower	O
panels	O
in	O
Fig	O
.	O
5a	O
),	O
which	O
indicates	O
that	O
the	O
PhDY	O
tag	O
did	O
not	O
affect	O
the	O
cholesterol	O
uptake	O
process	O
.	O

Then	O
,	O
we	O
tuned	O
the	O
laser	O
to	O
be	O
resonant	O
with	O
C	O
–	O
H	O
vibration	O
for	O
lipid	O
-	O
rich	O
LDs	O
.	O

Unlike	O
CHO	O
cells	O
,	O
the	O
PhDY	O
-	O
Chol	O
-	O
rich	O
compartments	O
were	O
found	O
to	O
be	O
distinguished	O
from	O
LDs	O
in	O
wildtype	O
worms	O
(	O
upper	O
panels	O
in	O
Fig	O
.	O
5a	O
).	O

To	O
explore	O
the	O
nature	O
of	O
PhDY	O
-	O
Chol	O
-	O
rich	O
compartments	O
found	O
in	O
our	O
study	O
,	O
we	O
used	O
hjIs9	O
worms	O
that	O
contain	O
GFP	B-GP
targeted	O
to	O
lysosome	O
-	O
related	O
organelles	O
(	O
LROs	O
)	O
in	O
intestinal	O
cells46	O
.	O

Dual	O
-	O
modality	O
SRS	O
and	O
TPEF	O
imaging	O
showed	O
that	O
PhDY	O
-	O
Chol	O
is	O
stored	O
in	O
the	O
LROs	O
(	O
Fig	O
.	O
5b	O
).	O

We	O
further	O
confirmed	O
the	O
cholesterol	O
storage	O
in	O
intestinal	O
LROs	O
by	O
combining	O
TPEF	O
imaging	O
of	O
GFP	B-GP
targeted	O
LROs	O
and	O
Raman	O
spectral	O
analysis	O
of	O
hjIs9	O
worms	O
fed	O
with	O
normal	O
cholesterol	O
(	O
Supplementary	O
Fig	O
.	O
8	O
).	O

Raman	O
spectrum	O
of	O
LROs	O
showed	O
peaks	O
for	O
sterol	O
C	O
=	O
C	O
bond	O
at	O
1	O
,	O
667	O
cm	O
−	O
1	O
and	O
Fermi	O
resonance	O
between	O
asymmetrical	O
CH2	O
vibrational	O
modes	O
at	O
2	O
,	O
875	O
cm	O
−	O
1	O
,	O
indicating	O
the	O
presence	O
of	O
cholesterol	O
in	O
this	O
organelle	O
.	O

Collectively	O
,	O
these	O
results	O
suggest	O
that	O
dietary	O
PhDY	O
-	O
Chol	O
uptake	O
is	O
through	O
a	O
ChUP	B-GP
-	I-GP
1	I-GP
mediated	O
process	O
,	O
and	O
unlike	O
mammalian	O
CHO	O
cells	O
,	O
C	B-OG
.	I-OG
elegans	I-OG
stores	O
cholesterol	O
in	O
LROs	O
,	O
but	O
not	O
in	O
LDs	O
in	O
the	O
intestine	O
.	O

Discussion	O

In	O
this	O
study	O
,	O
we	O
have	O
developed	O
a	O
series	O
of	O
tagged	O
cholesterols	O
based	O
on	O
quantum	O
chemistry	O
calculations	O
and	O
chemical	O
synthesis	O
.	O

By	O
using	O
PhDY	O
to	O
replace	O
the	O
aliphatic	O
chain	O
in	O
cholesterol	O
,	O
we	O
produced	O
a	O
cholesterol	O
analog	O
,	O
PhDY	O
-	O
Chol	O
,	O
with	O
a	O
Raman	O
signal	O
that	O
is	O
two	O
orders	O
of	O
magnitude	O
stronger	O
than	O
the	O
C	O
=	O
O	O
group	O
.	O

By	O
SRS	O
imaging	O
of	O
live	O
CHO	O
cells	O
,	O
PhDY	O
-	O
Chol	O
was	O
found	O
to	O
be	O
incorporated	O
into	O
the	O
membrane	O
,	O
and	O
converted	O
to	O
PhDY	O
-	O
cholesteryl	O
ester	O
for	O
storage	O
in	O
LDs	O
.	O

With	O
this	O
cholesterol	O
analog	O
,	O
we	O
experimentally	O
validated	O
that	O
after	O
ACAT	B-GP
-	I-GP
1	I-GP
inhibition	O
,	O
cholesterol	O
partly	O
accumulates	O
in	O
lysosomes	O
.	O

In	O
live	O
NPC1	B-GP
-	O
deleted	O
CHO	O
cells	O
,	O
PhDY	O
-	O
Chol	O
selectively	O
represented	O
lysosomal	O
accumulation	O
of	O
cholesterol	O
in	O
untreated	O
cells	O
,	O
and	O
esterification	O
and	O
relocation	O
to	O
LDs	O
after	O
HPβCD	O
treatment	O
.	O

Lastly	O
,	O
SRS	O
imaging	O
of	O
PhDY	O
-	O
Chol	O
in	O
live	O
C	B-OG
.	I-OG
elegans	I-OG
showed	O
cholesterol	O
uptake	O
by	O
intestinal	O
cells	O
,	O
and	O
indicated	O
LROs	O
,	O
but	O
not	O
LDs	O
,	O
as	O
the	O
cholesterol	O
storage	O
compartments	O
in	O
the	O
intestine	O
.	O

Essential	O
parameters	O
of	O
a	O
valid	O
Raman	O
tag	O
include	O
its	O
amplitude	O
of	O
Raman	O
scattering	O
cross	O
section	O
,	O
cytotoxicity	O
,	O
and	O
biocompatibility	O
.	O

Although	O
the	O
C	O
–	O
D	O
bond	O
can	O
be	O
used	O
to	O
replace	O
C	O
–	O
H	O
bonds	O
without	O
changing	O
the	O
structures	O
of	O
the	O
molecules	O
,	O
it	O
gives	O
relatively	O
weak	O
Raman	O
intensities	O
.	O

Raman	O
signal	O
from	O
alkyne	O
bond	O
is	O
stronger	O
than	O
that	O
from	O
C	O
–	O
D	O
bond	O
by	O
one	O
order	O
of	O
magnitude27	O
,	O
and	O
detection	O
at	O
hundreds	O
of	O
micromolar	O
of	O
alkyne	O
-	O
containing	O
molecules	O
by	O
SRS	O
microscopy	O
was	O
reported3536	O
.	O

It	O
should	O
be	O
noted	O
that	O
terminal	O
alkyne	O
is	O
known	O
to	O
react	O
with	O
the	O
cysteine	O
residues	O
in	O
proteins47	O
,	O
which	O
might	O
induce	O
cytotoxicity	O
at	O
micromolar	O
concentrations	O
.	O

In	O
our	O
study	O
,	O
through	O
rational	O
design	O
and	O
synthesis	O
of	O
a	O
PhDY	O
tag	O
,	O
we	O
increased	O
the	O
Raman	O
scattering	O
cross	O
section	O
by	O
15	O
times	O
compared	O
to	O
the	O
alkyne	O
group	O
,	O
and	O
88	O
times	O
compared	O
to	O
the	O
endogenous	O
C	O
=	O
O	O
group	O
.	O

This	O
enhancement	O
is	O
a	O
result	O
of	O
conjugation	O
of	O
π	O
-	O
electrons	O
among	O
the	O
two	O
C	O
≡	O
C	O
bonds	O
and	O
the	O
phenyl	O
group	O
.	O

As	O
a	O
result	O
,	O
we	O
have	O
been	O
able	O
to	O
detect	O
~	O
30	O
μM	O
of	O
PhDY	O
-	O
Chol	O
molecules	O
(~	O
1	O
,	O
800	O
molecules	O
at	O
excitation	O
volume	O
),	O
and	O
demonstrated	O
SRS	O
imaging	O
of	O
PhDY	O
-	O
Chol	O
in	O
single	O
membrane	O
at	O
speed	O
of	O
6	O
μs	O
per	O
pixel	O
,	O
and	O
a	O
real	O
-	O
time	O
movie	O
of	O
PhDY	O
-	O
Chol	O
containing	O
LDs	O
.	O

Importantly	O
,	O
this	O
design	O
also	O
shielded	O
the	O
activity	O
of	O
terminal	O
alkyne	O
and	O
significantly	O
reduced	O
cytotoxicity	O
.	O

Moreover	O
,	O
PhDY	O
-	O
Chol	O
structurally	O
mimics	O
cholesterol	O
,	O
using	O
the	O
same	O
physiological	O
process	O
for	O
cholesterol	O
transport	O
and	O
metabolism	O
inside	O
cells	O
.	O

Cell	O
membrane	O
morphology	O
did	O
not	O
alter	O
when	O
PhDY	O
-	O
Chol	O
was	O
supplemented	O
at	O
high	O
concentrations	O
when	O
compared	O
to	O
the	O
cells	O
supplemented	O
with	O
the	O
same	O
concentrations	O
of	O
cholesterol	O
(	O
Supplementary	O
Fig	O
.	O
3	O
).	O

Moreover	O
,	O
the	O
fluorescent	O
property	O
of	O
pyrenedecanoic	O
acid	O
,	O
a	O
membrane	O
fluidity	O
indicator48	O
,	O
did	O
not	O
change	O
after	O
CHO	O
cells	O
were	O
treated	O
with	O
50	O
μM	O
of	O
PhDY	O
-	O
Chol	O
or	O
50	O
μM	O
of	O
cholesterol	O
for	O
16	O
h	O
.	O

These	O
evaluations	O
suggest	O
that	O
the	O
membrane	O
property	O
of	O
the	O
cells	O
was	O
not	O
significantly	O
affected	O
by	O
addition	O
of	O
PhDY	O
-	O
Chol	O
or	O
cholesterol	O
under	O
our	O
experimental	O
conditions	O
.	O

We	O
note	O
that	O
using	O
the	O
same	O
strategy	O
,	O
other	O
Raman	O
tag	O
molecules	O
can	O
be	O
designed	O
for	O
sensitive	O
and	O
biocompatible	O
probing	O
of	O
biomolecules	O
in	O
live	O
cells	O
.	O

The	O
potential	O
value	O
of	O
a	O
Raman	O
tag	O
is	O
also	O
related	O
to	O
the	O
detection	O
sensitivity	O
of	O
SRS	O
microscopy	O
.	O

One	O
limitation	O
comes	O
from	O
the	O
cross	O
phase	O
modulation	O
,	O
which	O
produces	O
a	O
background	O
that	O
reduces	O
the	O
contrast	O
for	O
the	O
tag	O
molecules	O
.	O

Although	O
broadband	O
femtosecond	O
lasers	O
provide	O
high	O
peak	O
intensity	O
to	O
enhance	O
the	O
SRS	O
signal32	O
,	O
they	O
also	O
increase	O
the	O
amplitude	O
of	O
the	O
cross	O
phase	O
modulation	O
.	O

As	O
shown	O
in	O
our	O
study	O
,	O
this	O
background	O
can	O
be	O
reduced	O
by	O
3	O
times	O
using	O
spectral	O
focusing39	O
.	O

The	O
spectral	O
focusing	O
approach	O
also	O
increases	O
the	O
spectral	O
selectivity	O
,	O
reduces	O
the	O
photodamage	O
,	O
and	O
provides	O
opportunities	O
to	O
conduct	O
hyperspectral	O
SRS	O
imaging49	O
.	O

In	O
this	O
study	O
,	O
we	O
compared	O
BODIPY	O
-	O
cholesterol21	O
and	O
PhDY	O
-	O
Chol	O
.	O

Our	O
results	O
show	O
that	O
PhDY	O
-	O
Chol	O
is	O
stored	O
in	O
LDs	O
via	O
esterification	O
which	O
can	O
be	O
blocked	O
by	O
ACAT	B-GP
-	I-GP
1	I-GP
inhibition	O
.	O

In	O
contrast	O
,	O
BODIPY	O
-	O
cholesterol	O
labels	O
LDs	O
even	O
after	O
ACAT	B-GP
-	I-GP
1	I-GP
inhibition	O
.	O

This	O
result	O
may	O
be	O
due	O
to	O
the	O
strong	O
hydrophobic	O
interaction	O
of	O
BODIPY	O
with	O
LDs	O
,	O
and	O
is	O
consistent	O
with	O
previous	O
studies	O
showing	O
that	O
BODIPY	O
-	O
cholesterol	O
is	O
hardly	O
esterified	O
by	O
ACAT	B-GP
-	I-GP
1	I-GP
inside	O
the	O
cells21	O
.	O

These	O
results	O
demonstrate	O
that	O
PhDY	O
-	O
Chol	O
,	O
but	O
not	O
BODIPY	O
-	O
cholesterol	O
,	O
reflects	O
the	O
intracellular	O
behavior	O
of	O
free	O
cholesterol	O
.	O

We	O
also	O
showed	O
that	O
PhDY	O
-	O
Chol	O
reflects	O
the	O
location	O
of	O
the	O
cholesterol	O
in	O
real	O
-	O
time	O
,	O
unlike	O
filipin	O
staining	O
,	O
which	O
requires	O
fixation	O
.	O

Lastly	O
,	O
SRS	O
microscopy	O
utilizes	O
chemical	O
-	O
bond	O
vibrational	O
signals	O
for	O
visualization	O
.	O

Thus	O
,	O
unlike	O
fluorophores	O
,	O
the	O
PhDY	O
tag	O
does	O
not	O
undergo	O
bleaching	O
(	O
Supplementary	O
Fig	O
.	O
9	O
),	O
in	O
contrast	O
to	O
BODIPY	O
-	O
cholesterol	O
and	O
DHE15	O
which	O
is	O
known	O
to	O
have	O
a	O
rapid	O
photo	O
-	O
bleaching	O
rate	O
.	O

Combining	O
these	O
unique	O
properties	O
,	O
PhDY	O
-	O
Chol	O
allows	O
quantitative	O
imaging	O
of	O
intracellular	O
cholesterol	O
,	O
and	O
repetitive	O
observation	O
of	O
the	O
same	O
sample	O
before	O
and	O
after	O
treatment	O
.	O

Our	O
work	O
opens	O
new	O
opportunities	O
for	O
mechanistic	O
study	O
of	O
the	O
NP	B-DS
-	I-DS
C	I-DS
disease	I-DS
,	O
a	O
fatal	O
neurodegenerative	B-DS
disease	I-DS
that	O
shows	O
extensive	O
lysosomal	O
accumulation	O
of	O
cholesterol	O
.	O

Early	O
detection	O
methods	O
and	O
treatment	O
strategies	O
of	O
this	O
disease	O
are	O
still	O
under	O
development11	O
.	O

The	O
involvement	O
of	O
lysosomal	O
cholesterol	O
accumulation	O
to	O
the	O
neurodegeneration	O
is	O
still	O
unclear50	O
.	O

Our	O
in	O
vitro	O
study	O
shows	O
the	O
cholesterol	O
trafficking	O
and	O
metabolism	O
in	O
a	O
cellular	O
model	O
.	O

This	O
can	O
be	O
extended	O
to	O
in	O
vivo	O
studies	O
using	O
suitable	O
mouse	B-OG
models	O
to	O
understand	O
the	O
progression	O
of	O
the	O
disease	O
and	O
impact	O
of	O
potential	O
therapeutic	O
strategies	O
,	O
especially	O
in	O
central	O
nervous	O
system	O
.	O

C	B-OG
.	I-OG
elegans	I-OG
is	O
an	O
important	O
model	O
for	O
genetic	O
and	O
chemical	O
screening	O
in	O
many	O
diseases51	O
.	O

It	O
has	O
been	O
proposed	O
that	O
the	O
intracellular	O
sterol	O
trafficking	O
pathway	O
might	O
be	O
conserved	O
in	O
nematodes52	O
,	O
making	O
it	O
a	O
good	O
model	O
for	O
exploring	O
the	O
genetics	O
of	O
fat	O
storage	O
and	O
lipid	O
metabolism53	O
.	O

However	O
,	O
lipid	O
storage	O
in	O
C	B-OG
.	I-OG
elegans	I-OG
has	O
been	O
a	O
debate	O
because	O
of	O
limitations	O
and	O
controversies	O
of	O
the	O
visualization	O
tool	O
for	O
lipids5455	O
,	O
especially	O
cholesterol	O
.	O

Filipin	O
labeling	O
causes	O
sterol	O
extraction	O
and	O
some	O
tissues	O
were	O
not	O
accessible	O
with	O
staining2056	O
.	O

Imaging	O
fluorescent	O
cholesterol	O
in	O
C	B-OG
.	I-OG
elegans	I-OG
is	O
a	O
challenge	O
due	O
to	O
strong	O
and	O
spectrally	O
overlapping	O
autofluorescence	O
from	O
the	O
worm57	O
.	O

Using	O
label	O
-	O
free	O
coherent	O
anti	O
-	O
Stokes	O
Raman	O
scattering	O
(	O
CARS	O
)	O
microscopy	O
,	O
fat	O
storage	O
compartments	O
in	O
C	B-OG
.	I-OG
elegans	I-OG
were	O
studied5859	O
.	O

However	O
,	O
single	O
color	O
CARS	O
microscopy	O
based	O
on	O
the	O
signal	O
from	O
C	O
–	O
H	O
stretching	O
vibrations	O
cannot	O
tell	O
the	O
compositions	O
of	O
the	O
LDs	O
,	O
and	O
so	O
far	O
it	O
is	O
not	O
clear	O
where	O
the	O
cholesterol	O
is	O
stored	O
inside	O
the	O
worms	O
.	O

By	O
combination	O
of	O
chemical	O
synthesis	O
of	O
PhDY	O
-	O
Chol	O
and	O
real	O
-	O
time	O
SRS	O
imaging	O
,	O
we	O
found	O
evidences	O
suggesting	O
the	O
cholesterol	O
storage	O
in	O
LROs	O
.	O

Label	O
-	O
free	O
Raman	O
spectral	O
analysis	O
was	O
performed	O
to	O
validate	O
the	O
finding	O
.	O

Sterol	O
uptake	O
and	O
transport	O
in	O
worms	O
are	O
still	O
poorly	O
understood45	O
,	O
and	O
SRS	O
imaging	O
of	O
PhDY	O
-	O
Chol	O
opens	O
an	O
avenue	O
to	O
directly	O
assess	O
cholesterol	O
uptake	O
and	O
transport	O
for	O
genome	O
-	O
wide	O
RNA	O
interference	O
screening	O
of	O
cholesterol	O
transport	O
and	O
storage	O
genes	O
in	O
this	O
animal	B-OG
model	O
.	O

Finally	O
,	O
our	O
work	O
also	O
opens	O
new	O
opportunities	O
to	O
study	O
cholesterol	O
trafficking	O
and	O
metabolism	O
in	O
other	O
animal	B-OG
models	O
such	O
as	O
zebrafish	B-OG
and	O
mice	B-OG
.	O

Methods	O

Calculation	O
of	O
Raman	O
intensity	O

All	O
calculations	O
were	O
performed	O
at	O
the	O
HF	O
/	O
6	O
-	O
311G	O
*	O
level	O
of	O
theory	O
.	O

Geometry	O
optimizations	O
,	O
vibrational	O
frequencies	O
and	O
Raman	O
intensities	O
are	O
obtained	O
in	O
Q	O
-	O
Chem	O
electronic	O
structure	O
package60	O
.	O

Localized	O
polarizabilities	O
are	O
calculated	O
in	O
the	O
GAMESS	O
quantum	O
chemistry	O
software61	O
.	O

Chemicals	O

3β	O
-	O
hydroxy	O
-	O
Δ5	O
-	O
cholenic	O
acid	O
was	O
purchased	O
from	O
VWR	O
.	O

Lipoprotein	O
-	O
deficient	O
serum	O
was	O
purchased	O
from	O
Biomedical	O
Technologies	O
Inc	O
.	O

Cholesterol	O
,	O
avasimibe	O
,	O
and	O
filipin	O
complex	O
were	O
purchased	O
from	O
Sigma	O
-	O
Aldrich	O
.	O

BODIPY	O
-	O
cholesterol	O
was	O
purchased	O
from	O
Avanti	O
Polar	O
Lipids	O
,	O
Inc	O
.	O

Propidium	O
iodide	O
,	O
BODIPY	O
,	O
and	O
LysoTracker	O
were	O
purchased	O
from	O
Life	O
technologies	O
.	O

Synthesis	O
of	O
Raman	O
-	O
tagged	O
cholesterol	O

Detailed	O
synthesis	O
procedures	O
and	O
characterization	O
of	O
compounds	O
are	O
shown	O
in	O
Supplementary	O
Information	O
.	O

Solubilization	O
of	O
tagged	O
cholesterol	O

To	O
solubilize	O
the	O
tagged	O
cholesterol	O
molecules	O
,	O
the	O
following	O
procedure	O
was	O
used	O
to	O
prepare	O
a	O
stock	O
solution	O
of	O
10	O
mM	O
cholesterol	O
probe	O
molecules	O
.	O

The	O
appropriate	O
amount	O
of	O
cholesterol	O
probe	O
powder	O
was	O
dissolved	O
in	O
100	O
%	O
ethanol	O
to	O
make	O
a	O
20	O
mM	O
solution	O
.	O

The	O
tube	O
was	O
vortexed	O
and	O
then	O
sonicated	O
in	O
bath	O
sonicator	O
for	O
2	O
min	O
.	O

The	O
same	O
volume	O
of	O
DMSO	O
was	O
added	O
into	O
the	O
tube	O
,	O
vortexed	O
,	O
and	O
then	O
sonicated	O
in	O
bath	O
sonicator	O
for	O
2	O
min	O
.	O

BODIPY	O
-	O
cholesterol	O
was	O
prepared	O
with	O
the	O
same	O
procedure	O
.	O

For	O
SRS	O
imaging	O
and	O
Raman	O
spectral	O
analysis	O
of	O
tagged	O
cholesterol	O
solutions	O
,	O
cholesterol	O
probe	O
molecules	O
were	O
prepared	O
in	O
cyclohexanone	O
at	O
50	O
mM	O
.	O

The	O
tube	O
was	O
vortexed	O
and	O
then	O
sonicated	O
in	O
bath	O
sonicator	O
for	O
2	O
min	O
.	O

1	O
μL	O
of	O
the	O
solution	O
was	O
taken	O
to	O
prepare	O
cover	O
glass	O
samples	O
immediately	O
before	O
use	O
.	O

Cell	O
culture	O
and	O
PhDY	O
-	O
Chol	O
treatment	O

CHO	O
-	O
K1	O
cells	O
and	O
M12	O
cells	O
(	O
mutant	O
CHO	O
-	O
K1	O
cells	O
that	O
contain	O
a	O
deletion	O
of	O
the	O
NPC1	B-GP
locus42	O
)	O
were	O
kindly	O
provided	O
by	O
Dr	O
.	O
Daniel	O
Ory	O
,	O
and	O
were	O
grown	O
in	O
a	O
monolayer	O
at	O
37	O
°	O
C	O
in	O
5	O
%	O
CO2	O
in	O
DMEM	O
/	O
F	O
-	O
12	O
medium	O
supplemented	O
with	O
10	O
%	O
(	O
vol	O
/	O
vol	O
)	O
FBS	O
.	O

To	O
incubate	O
cells	O
with	O
PhDY	O
-	O
Chol	O
,	O
cells	O
were	O
pre	O
-	O
incubated	O
in	O
DMEM	O
/	O
F	O
-	O
12	O
medium	O
supplemented	O
with	O
4	O
.	O
4	O
%	O
lipoprotein	O
-	O
deficient	O
serum	O
to	O
deplete	O
medium	O
cholesterol	O
for	O
16	O
h	O
.	O

The	O
cells	O
were	O
then	O
incubated	O
with	O
PhDY	O
-	O
Chol	O
containing	O
medium	O
(	O
DMEM	O
/	O
F	O
-	O
12	O
+	O
4	O
.	O
4	O
%	O
lipoprotein	O
-	O
deficient	O
serum	O
+	O
50	O
μM	O
PhDY	O
-	O
Chol	O
)	O
for	O
16	O
h	O
to	O
24	O
h	O
.	O

Cells	O
were	O
rinsed	O
with	O
1	O
×	O
PBS	O
buffer	O
three	O
times	O
before	O
the	O
next	O
procedure	O
.	O

Raman	O
spectromicroscopy	O

The	O
background	O
of	O
Raman	O
spectrum	O
was	O
removed	O
as	O
described62	O
.	O

Each	O
Raman	O
spectrum	O
of	O
tagged	O
cholesterol	O
solution	O
was	O
acquired	O
in	O
10	O
seconds	O
,	O
and	O
each	O
Raman	O
spectrum	O
of	O
fluorescence	O
stained	O
cells	O
was	O
acquired	O
in	O
30	O
seconds	O
.	O

On	O
the	O
same	O
microscope	O
,	O
TPEF	O
imaging	O
was	O
performed	O
with	O
707	O
nm	O
laser	O
with	O
100	O
mW	O
power	O
.	O

Backward	O
-	O
detected	O
two	O
-	O
photon	O
fluorescence	O
signal	O
was	O
collected	O
through	O
a	O
425	O
/	O
40	O
nm	O
or	O
522	O
/	O
40	O
nm	O
band	O
-	O
pass	O
filter	O
for	O
imaging	O
filipin	O
or	O
BODIPY	O
fluorescence	O
,	O
respectively	O
.	O

SRS	O
microscopy	O

SRS	O
imaging	O
was	O
performed	O
on	O
a	O
femtosecond	O
SRL	O
microscope	O
,	O
with	O
the	O
laser	O
beating	O
frequency	O
tuned	O
to	O
the	O
C	O
≡	O
C	O
vibration	O
band	O
at	O
2	O
,	O
254	O
cm	O
−	O
1	O
,	O
or	O
to	O
the	O
C	O
–	O
H	O
vibration	O
band	O
at	O
2	O
,	O
885	O
cm	O
−	O
1	O
,	O
as	O
described	O
previously32	O
.	O

The	O
laser	O
power	O
at	O
the	O
specimen	O
was	O
maintained	O
at	O
75	O
mW	O
,	O
and	O
no	O
cell	O
or	O
tissue	O
damage	O
was	O
observed	O
.	O

For	O
off	O
-	O
resonance	O
,	O
2	O
,	O
099	O
cm	O
−	O
1	O
was	O
used	O
.	O

On	O
the	O
same	O
microscope	O
,	O
TPEF	O
imaging	O
was	O
performed	O
with	O
843	O
nm	O
laser	O
with	O
30	O
mW	O
power	O
.	O

Forward	O
-	O
detected	O
two	O
-	O
photon	O
fluorescence	O
signal	O
was	O
collected	O
through	O
an	O
appropriate	O
band	O
-	O
pass	O
filter	O
for	O
imaging	O
filipin	O
,	O
BODIPY	O
,	O
or	O
LysoTracker	O
.	O

ACAT	B-GP
-	I-GP
1	I-GP
inhibition	O

ACAT	B-GP
-	I-GP
1	I-GP
inhibition	O
was	O
used	O
to	O
block	O
cholesterol	O
esterification	O
either	O
by	O
adding	O
a	O
potent	O
ACAT	B-GP
inhibitor	O
,	O
avasimibe	O
,	O
or	O
by	O
RNA	O
interference	O
with	O
ACAT	B-GP
-	I-GP
1	I-GP
shRNA	O
plasmid	O
.	O

Avasimibe	O
:	O
Cells	O
were	O
pre	O
-	O
treated	O
with	O
avasimibe	O
at	O
a	O
final	O
concentration	O
of	O
10	O
μM	O
for	O
24	O
h	O
.	O

Then	O
PhDY	O
-	O
Chol	O
containing	O
medium	O
with	O
10	O
μM	O
avasimibe	O
was	O
added	O
into	O
the	O
cells	O
and	O
incubated	O
for	O
24	O
h	O
.	O

RNA	O
interference	O
:	O
RNA	O
interference	O
was	O
employed	O
to	O
specifically	O
inhibit	O
endogenous	O
ACAT	B-GP
-	I-GP
1	I-GP
.	O

The	O
ACAT	B-GP
-	I-GP
1	I-GP
shRNA	O
plasmid	O
was	O
purchased	O
from	O
Santa	O
Cruz	O
(	O
sc	O
-	O
29624	O
-	O
SH	O
).	O

shRNA	O
plasmid	O
was	O
transfected	O
with	O
Lipofectamine	O
®	O
2000	O
(	O
Invitrogen	O
11668030	O
)	O
as	O
described	O
in	O
the	O
manufacturer	O
'	O
s	O
protocols	O
.	O

HPβCD	O
treatment	O

HPβCD	O
was	O
used	O
as	O
a	O
drug	O
treatment	O
of	O
NP	B-DS
-	I-DS
C	I-DS
disease	I-DS
.	O

M12	O
cells	O
were	O
incubated	O
with	O
PhDY	O
-	O
Chol	O
for	O
16	O
h	O
as	O
described	O
above	O
.	O

Then	O
cells	O
were	O
treated	O
with	O
500	O
μM	O
HPβCD	O
for	O
30	O
h	O
.	O

Cell	O
-	O
viability	O
assay	O

CHO	O
cells	O
were	O
grown	O
in	O
96	O
-	O
well	O
plates	O
with	O
density	O
of	O
4000	O
cells	O
per	O
well	O
.	O

The	O
next	O
day	O
,	O
the	O
cells	O
were	O
treated	O
with	O
each	O
cholesterol	O
probe	O
at	O
the	O
indicated	O
concentrations	O
for	O
48	O
h	O
.	O

Cell	O
-	O
viability	O
was	O
measured	O
with	O
the	O
MTT	O
colorimetric	O
assay	O
(	O
Sigma	O
).	O

Propidium	O
iodide	O
staining	O

Propidium	O
iodide	O
was	O
used	O
to	O
stain	O
late	O
apoptotic	O
or	O
necrotic	O
cells	O
.	O

CHO	O
cells	O
were	O
incubated	O
with	O
30	O
μM	O
of	O
tagged	O
cholesterol	O
molecules	O
for	O
24	O
h	O
.	O

The	O
propidium	O
iodide	O
staining	O
was	O
performed	O
following	O
protocols	O
provided	O
by	O
the	O
manufacturer	O
(	O
Life	O
Technologies	O
).	O

Fluorescent	O
staining	O
of	O
free	O
cholesterol	O
,	O
LDs	O
,	O
and	O
lysosomes	O

Filipin	O
was	O
used	O
to	O
stain	O
free	O
cholesterol	O
.	O

Cells	O
were	O
fixed	O
with	O
10	O
%	O
formalin	O
solution	O
(	O
Sigma	O
)	O
for	O
1	O
h	O
at	O
room	O
temperature	O
.	O

1	O
.	O
5	O
mg	O
/	O
mL	O
glycine	O
in	O
PBS	O
was	O
used	O
to	O
quench	O
the	O
formalin	O
by	O
incubating	O
the	O
fixed	O
cells	O
for	O
10	O
minutes	O
at	O
room	O
temperature	O
.	O

To	O
stain	O
the	O
cells	O
with	O
filipin	O
,	O
working	O
solution	O
of	O
0	O
.	O
05	O
mg	O
/	O
mL	O
of	O
filipin	O
in	O
PBS	O
/	O
10	O
%	O
FBS	O
was	O
used	O
to	O
incubate	O
cells	O
for	O
2	O
h	O
at	O
room	O
temperature	O
.	O

BODIPY	O
was	O
used	O
to	O
label	O
LDs	O
.	O

Cells	O
were	O
incubated	O
with	O
10	O
μg	O
/	O
mL	O
of	O
BODIPY	O
for	O
30	O
minutes	O
at	O
room	O
temperature	O
.	O

LysoTracker	O
Yellow	O
-	O
HCK	O
-	O
123	O
was	O
used	O
to	O
stain	O
lysosomes	O
following	O
protocols	O
provided	O
by	O
the	O
manufacturer	O
(	O
Life	O
Technologies	O
).	O

Cells	O
were	O
rinsed	O
with	O
PBS	O
three	O
times	O
before	O
TPEF	O
imaging	O
.	O

C	B-OG
.	I-OG
elegans	I-OG
strains	O

The	O
N2	O
Bristol	O
was	O
used	O
as	O
wild	O
-	O
type	O
strain	O
.	O

VC452	O
strain	O
with	O
chup	B-GP
-	I-GP
1	I-GP
(	O
gk245	O
)	O
X	O
genotype	O
was	O
used	O
to	O
study	O
PhDY	O
-	O
Chol	O
uptake	O
.	O

VS17	O
strain	O
with	O
hjIs9	O
[	O
ges	B-GP
-	I-GP
1p	I-GP
::	O
glo	B-GP
-	I-GP
1	I-GP
::	O
GFP	B-GP
+	O
unc	B-GP
-	I-GP
119	I-GP
(+)]	O
genotype	O
was	O
used	O
to	O
study	O
cholesterol	O
storage	O
in	O
LROs	O
.	O

PhDY	O
-	O
Chol	O
uptake	O
into	O
C	B-OG
.	I-OG
elegans	I-OG

PhDY	O
-	O
Chol	O
uptake	O
procedure	O
was	O
modified	O
from	O
a	O
previously	O
reported	O
procedure20	O
.	O

Briefly	O
,	O
500	O
μM	O
of	O
PhDY	O
-	O
Chol	O
in	O
DMSO	O
was	O
spread	O
on	O
the	O
NGM	O
plates	O
seeded	O
with	O
an	O
E	B-OG
.	I-OG
coli	I-OG
OP50	I-OG
lawn	O
and	O
allowed	O
to	O
grow	O
overnight	O
at	O
room	O
temperature	O
.	O
C	B-OG
.	I-OG
elegans	I-OG
was	O
then	O
transferred	O
to	O
PhDY	O
-	O
Chol	O
containing	O
plates	O
and	O
grown	O
for	O
3	O
days	O
before	O
SRS	O
imaging	O
.	O

Statistical	O
analysis	O

To	O
quantify	O
PhDY	O
-	O
rich	O
area	O
,	O
we	O
first	O
selected	O
one	O
cell	O
and	O
used	O
“	O
Threshold	O
”	O
function	O
to	O
select	O
PhDY	O
-	O
rich	O
cellular	O
regions	O
using	O
ImageJ	O
.	O

Then	O
,	O
by	O
using	O
“	O
Analyze	O
Particles	O
”	O
function	O
,	O
the	O
area	O
fraction	O
(%)	O
of	O
PhDY	O
-	O
rich	O
region	O
was	O
obtained	O
.	O

To	O
quantify	O
PhDY	O
-	O
rich	O
LDs	O
,	O
“	O
Image	O
Calculator	O
”	O
function	O
in	O
ImageJ	O
was	O
used	O
to	O
multiply	O
SRS	O
image	O
of	O
PhDY	O
-	O
Chol	O
by	O
TPEF	O
image	O
of	O
BODIPY	O
.	O

Then	O
,	O
after	O
using	O
“	O
Threshold	O
”	O
function	O
to	O
select	O
PhDY	O
-	O
rich	O
LDs	O
,	O
the	O
number	O
of	O
PhDY	O
-	O
rich	O
LDs	O
was	O
counted	O
by	O
“	O
Analyze	O
Particles	O
”	O
function	O
.	O

For	O
each	O
group	O
,	O
7	O
cells	O
were	O
analyzed	O
,	O
and	O
results	O
were	O
shown	O
as	O
mean	O
±	O
standard	O
deviation	O
(	O
SD	O
).	O

Student	O
'	O
s	O
t	O
test	O
was	O
used	O
for	O
all	O
the	O
comparisons	O
.	O
p	O
<	O
0	O
.	O
05	O
was	O
considered	O
statistically	O
significant	O
.	O

Author	O
Contributions	O

M	O
.	O
D	O
.	O
and	O
J	O
.	O
X	O
.	O
C	O
.	O
designed	O
the	O
research	O
.	O

D	O
.	O
Z	O
.	O
and	O
L	O
.	O
V	O
.	O
S	O
.	O
performed	O
and	O
analyzed	O
the	O
quantum	O
chemistry	O
calculation	O
.	O

W	O
.	O
Z	O
.	O
and	O
Y	O
.	O
Y	O
.	O
synthesized	O
and	O
analyzed	O
the	O
compounds	O
.	O

H	O
.	O
J	O
.	O
L	O
.	O
and	O
D	O
.	O
Z	O
.	O
performed	O
and	O
analyzed	O
the	O
SRS	O
experiments	O
.	O

B	O
.	O
L	O
.	O
developed	O
dual	O
-	O
modality	O
imaging	O
.	O

E	O
.	O
L	O
.	O
B	O
.	O
and	O
K	O
.	O
K	O
.	O
B	O
.	O
provided	O
the	O
NP	B-DS
-	I-DS
C	I-DS
disease	I-DS
model	O
and	O
discussed	O
the	O
data	O
.	O

H	O
.	O
J	O
.	O
L	O
.	O
performed	O
and	O
analyzed	O
in	O
vitro	O
and	O
in	O
vivo	O
experiments	O
.	O

H	O
.	O
J	O
.	O
L	O
.,	O
W	O
.	O
Z	O
.,	O
M	O
.	O
D	O
.	O
and	O
J	O
.	O
X	O
.	O
C	O
.	O
wrote	O
the	O
manuscript	O
.	O

Supplementary	O
Material	O

Supplementary	O
Information	O

Supplementary	O
Movie	O

Supplementary	O
Information	O

Supplementary	O
Information	O

Reagents	O
and	O
conditions	O
:	O
(	O
a	O
)	O
DHP	O
(	O
5	O
.	O
0	O
equiv	O
),	O
p	O
-	O
TsOH	O
(	O
0	O
.	O
2	O
equiv	O
),	O
THF	O
,	O
RT	O
,	O
91	O
%;	O
(	O
b	O
)	O
LiAlH4	O
(	O
3	O
.	O
0	O
equiv	O
),	O
THF	O
,	O
0	O
°	O
C	O
to	O
RT	O
,	O
98	O
%;	O
(	O
c	O
)	O
DMP	O
(	O
3	O
.	O
0	O
equiv	O
),	O
NaHCO3	O
(	O
3	O
.	O
0	O
equiv	O
),	O
CH2Cl2	O
,	O
0	O
°	O
C	O
,	O
86	O
%;	O
(	O
d	O
)	O
dimethyl	O
(	O
1	O
-	O
diazo	O
-	O
2	O
-	O
oxopropyl	O
)	O
phosphonate	O
(	O
Bestmann	O
reagent	O
,	O
2	O
.	O
4	O
equiv	O
),	O
K2CO3	O
(	O
4	O
.	O
0	O
equiv	O
),	O
THF	O
/	O
MeOH	O
,	O
RT	O
,	O
99	O
%;	O
(	O
e	O
)	O
p	O
-	O
TsOH	O
(	O
1	O
.	O
0	O
equiv	O
),	O
THF	O
/	O
MeOH	O
,	O
RT	O
,	O
84	O
%;	O
(	O
f	O
)	O
Iodobenzene	O
(	O
1	O
.	O
02	O
equiv	O
),	O
PdCl2	O
(	O
PPh3	O
)	O
2	O
(	O
0	O
.	O
05	O
equiv	O
),	O
CuI	O
(	O
0	O
.	O
05	O
equiv	O
),	O
TEA	O
,	O
RT	O
;	O
then	O
p	O
-	O
TsOH	O
(	O
1	O
.	O
0	O
equiv	O
),	O
THF	O
/	O
MeOH	O
,	O
RT	O
,	O
77	O
%;	O
(	O
g	O
)	O
CuI	O
(	O
0	O
.	O
1	O
equiv	O
),	O
K2CO3	O
(	O
2	O
.	O
0	O
equiv	O
),	O
P	O
(	O
o	O
-	O
Tol	O
)	O
3	O
(	O
0	O
.	O
2	O
equiv	O
),	O
phenyl	O
bromoacetylene	O
(	O
1	O
.	O
3	O
equiv	O
),	O
EtOH	O
,	O
100	O
°	O
C	O
,	O
51	O
%;	O
(	O
h	O
)	O
p	O
-	O
TsOH	O
(	O
1	O
.	O
0	O
equiv	O
),	O
THF	O
/	O
MeOH	O
,	O
RT	O
,	O
95	O
%;	O
(	O
i	O
)	O
MsCl	O
(	O
3	O
.	O
0	O
equiv	O
),	O
TEA	O
(	O
3	O
.	O
0	O
equiv	O
),	O
CH2Cl2	O
,	O
0	O
°	O
C	O
to	O
RT	O
,	O
75	O
%;	O
(	O
j	O
)	O
KCN	O
(	O
2	O
.	O
0	O
equiv	O
),	O
DMSO	O
,	O
90	O
°	O
C	O
,	O
76	O
%;	O
(	O
k	O
)	O
p	O
-	O
TsOH	O
(	O
1	O
.	O
0	O
equiv	O
),	O
THF	O
/	O
MeOH	O
,	O
RT	O
,	O
74	O
%.	O

DHP	O
=	O
3	O
,	O
4	O
-	O
Dihydro	O
-	O
2H	O
-	O
pyran	O
,	O
DMP	O
=	O
Dess	O
-	O
Martin	O
Periodinane	O
,	O
p	O
-	O
TsOH	O
=	O
p	O
-	O
Toluenesulfonic	O
acid	O
,	O
TEA	O
=	O
triethylamine	O
,	O
P	O
(	O
o	O
-	O
Tol	O
)	O
3	O
=	O
tri	O
(	O
o	O
-	O
tolyl	O
)	O
phosphine	O
,	O
MsCl	O
=	O
methanesulfonyl	O
chloride	O
.	O

CN	O
:	O
cyano	O
;	O
A	O
:	O
alkyne	O
;	O
PhA	O
:	O
phenyl	O
-	O
alkyne	O
;	O
PhDY	O
:	O
phenyl	O
-	O
diyne	O
;	O
Chol	O
:	O
cholesterol	O
.	O

(	O
a	O
)	O
Raman	O
spectra	O
of	O
50	O
mM	O
tagged	O
cholesterols	O
in	O
cyclohexanone	O
(	O
solvent	O
).	O

Spectral	O
intensity	O
was	O
normalized	O
by	O
C	O
=	O
O	O
vibration	O
band	O
at	O
1	O
,	O
714	O
cm	O
−	O
1	O
.	O

Spectral	O
acquisition	O
time	O
:	O
10	O
s	O
.	O

(	O
b	O
)	O
Plot	O
of	O
relative	O
intensity	O
of	O
Raman	O
tags	O
versus	O
solvent	O
and	O
Raman	O
shifts	O
of	O
tagged	O
cholesterols	O
.	O

Based	O
on	O
the	O
molar	O
concentration	O
of	O
the	O
molecules	O
(	O
50	O
mM	O
)	O
and	O
the	O
solvent	O
(	O
9	O
.	O
7	O
M	O
),	O
the	O
Raman	O
cross	O
section	O
of	O
C	O
≡	O
C	O
from	O
A	O
-	O
Chol	O
,	O
PhA	O
-	O
Chol	O
,	O
and	O
PhDY	O
-	O
Chol	O
are	O
6	O
times	O
,	O
15	O
times	O
,	O
and	O
88	O
times	O
larger	O
than	O
the	O
C	O
=	O
O	O
band	O
from	O
the	O
solvent	O
,	O
respectively	O
.	O

CN	O
:	O
cyano	O
;	O
A	O
:	O
alkyne	O
;	O
PhA	O
:	O
phenyl	O
-	O
alkyne	O
;	O
PhDY	O
:	O
phenyl	O
-	O
diyne	O
;	O
Chol	O
:	O
cholesterol	O
.	O

(	O
c	O
)	O
SRS	O
contrast	O
versus	O
concentration	O
plot	O
of	O
PhDY	O
-	O
Chol	O
solutions	O
.	O

13	O
%	O
contrast	O
was	O
reached	O
at	O
313	O
μM	O
and	O
4	O
%	O
contrast	O
was	O
reached	O
at	O
156	O
μM	O
.	O

Image	O
acquisition	O
speed	O
:	O
200	O
μs	O
per	O
pixel	O
.	O

Data	O
represents	O
the	O
mean	O
±	O
SEM	O
in	O
3	O
measurements	O
.	O

R2	O
=	O
0	O
.	O
996	O
.	O

(	O
d	O
)	O
SRS	O
contrast	O
versus	O
concentration	O
plot	O
of	O
PhDY	O
-	O
Chol	O
solutions	O
using	O
chirped	O
femtosecond	O
lasers	O
with	O
spectral	O
focusing	O
approach	O
.	O

14	O
%	O
contrast	O
was	O
reached	O
at	O
31	O
μM	O
.	O

Image	O
acquisition	O
speed	O
:	O
200	O
μs	O
per	O
pixel	O
.	O

Data	O
represents	O
the	O
mean	O
±	O
SEM	O
in	O
3	O
measurements	O
.	O

R2	O
=	O
0	O
.	O
980	O
.	O

Contrast	O
was	O
defined	O
as	O
(	O
S	O
−	O
B	O
)/	O
B	O
.	O

S	O
:	O
SRS	O
signal	O
;	O
B	O
:	O
background	O
.	O

(	O
a	O
)	O
SRS	O
images	O
of	O
live	O
CHO	O
cells	O
treated	O
with	O
PhDY	O
-	O
Chol	O
(	O
50	O
μM	O
)	O
for	O
16	O
h	O
.	O

C	O
≡	O
C	O
vibrational	O
mode	O
at	O
2	O
,	O
254	O
cm	O
−	O
1	O
was	O
used	O
for	O
PhDY	O
-	O
Chol	O
,	O
and	O
C	O
–	O
H	O
vibrational	O
mode	O
at	O
2	O
,	O
885	O
cm	O
−	O
1	O
was	O
used	O
for	O
C	O
–	O
H	O
-	O
rich	O
lipid	O
structures	O
.	O

Lasers	O
were	O
also	O
tuned	O
away	O
to	O
2	O
,	O
099	O
cm	O
−	O
1	O
to	O
show	O
specificity	O
of	O
PhDY	O
-	O
Chol	O
signal	O
inside	O
the	O
cells	O
.	O

PhDY	O
-	O
Chol	O
was	O
found	O
to	O
accumulate	O
in	O
LDs	O
(	O
arrows	O
).	O

Image	O
acquisition	O
speed	O
:	O
10	O
μs	O
per	O
pixel	O
for	O
512	O
×	O
512	O
pixels	O
.	O

Scalar	O
bar	O
:	O
10	O
μm	O
.	O

(	O
b	O
)	O
Schematic	O
graph	O
showing	O
the	O
hypothesis	O
of	O
PhDY	O
-	O
Chol	O
metabolism	O
inside	O
the	O
cells	O
.	O

ACAT	O
-	O
1	O
:	O
Acyl	O
-	O
CoA	O
:	O
cholesterol	O
acyltransferase	O
.	O

(	O
c	O
)	O
SRS	O
images	O
of	O
PhDY	O
-	O
Chol	O
in	O
CHO	O
cells	O
and	O
ACAT	O
-	O
1	O
inhibited	O
CHO	O
cells	O
by	O
avasimibe	O
treatment	O
.	O

As	O
shown	O
in	O
circles	O
,	O
PhDY	O
-	O
Chol	O
was	O
stored	O
in	O
LDs	O
in	O
CHO	O
cells	O
,	O
but	O
not	O
in	O
avasimibe	O
treated	O
CHO	O
cells	O
.	O

Image	O
acquisition	O
speed	O
:	O
100	O
μs	O
per	O
pixel	O
for	O
400	O
×	O
400	O
pixels	O
.	O

Scalar	O
bar	O
:	O
10	O
μm	O
.	O

Intensity	O
bars	O
in	O
(	O
a	O
)	O
and	O
(	O
c	O
)	O
show	O
the	O
ΔI	O
/	O
I	O
of	O
the	O
SRS	O
image	O
.	O

(	O
d	O
)	O
Quantification	O
of	O
PhDY	O
-	O
rich	O
and	O
BODIPY	O
-	O
rich	O
LDs	O
in	O
CHO	O
cells	O
before	O
and	O
after	O
ACAT	O
-	O
1	O
inhibition	O
.	O

The	O
number	O
of	O
the	O
LDs	O
was	O
normalized	O
by	O
the	O
control	O
group	O
(	O
n	O
=	O
7	O
).	O

Error	O
bars	O
represent	O
standard	O
deviation	O
.	O
*:	O
p	O
<	O
0	O
.	O
05	O
.	O

(	O
e	O
)	O
TPEF	O
images	O
of	O
BODIPY	O
-	O
cholesterol	O
and	O
SRS	O
images	O
C	O
–	O
H	O
-	O
rich	O
structures	O
in	O
CHO	O
cells	O
and	O
ACAT	O
-	O
1	O
inhibited	O
CHO	O
cells	O
.	O

As	O
shown	O
in	O
circles	O
,	O
BODIPY	O
-	O
cholesterol	O
showed	O
no	O
difference	O
between	O
the	O
two	O
groups	O
.	O

Scalar	O
bar	O
:	O
10	O
μm	O
.	O

TPEF	O
images	O
of	O
filipin	O
and	O
SRS	O
images	O
PhDY	O
-	O
Chol	O
in	O
(	O
a	O
)	O
PhDY	O
-	O
Chol	O
-	O
loaded	O
M12	O
cells	O
,	O
and	O
(	O
b	O
)	O
the	O
same	O
cells	O
treated	O
with	O
HPβCD	O
(	O
500	O
μM	O
)	O
for	O
30	O
h	O
.	O

Arrows	O
indicate	O
PhDY	O
-	O
rich	O
area	O
labeled	O
by	O
filipin	O
before	O
treatment	O
(	O
non	O
-	O
esterified	O
PhDY	O
-	O
Chol	O
),	O
and	O
arrow	O
heads	O
indicate	O
PhDY	O
-	O
rich	O
area	O
not	O
labeled	O
by	O
filipin	O
after	O
treatment	O
(	O
esterified	O
PhDY	O
-	O
Chol	O
).	O

Green	O
intensity	O
bar	O
shows	O
the	O
ΔI	O
/	O
I	O
value	O
of	O
the	O
SRS	O
image	O
;	O
red	O
intensity	O
bar	O
represents	O
the	O
relative	O
intensity	O
of	O
fluorescence	O
.	O

Image	O
acquisition	O
speed	O
:	O
100	O
μs	O
per	O
pixel	O
for	O
400	O
×	O
400	O
pixels	O
.	O

Scalar	O
bar	O
:	O
10	O
μm	O
.	O

(	O
c	O
)	O
Quantification	O
of	O
PhDY	O
-	O
rich	O
area	O
in	O
the	O
cells	O
before	O
and	O
after	O
HPβCD	O
treatment	O
(	O
n	O
=	O
7	O
).	O

Error	O
bars	O
represent	O
standard	O
deviation	O
.	O
*:	O
p	O
<	O
0	O
.	O
05	O
.	O

(	O
d	O
)	O
TPEF	O
images	O
of	O
BODIPY	O
and	O
SRS	O
images	O
of	O
PhDY	O
-	O
Chol	O
in	O
M12	O
cells	O
treated	O
with	O
or	O
without	O
HPβCD	O
(	O
500	O
μM	O
)	O
for	O
30	O
h	O
.	O

Arrow	O
heads	O
indicate	O
LDs	O
without	O
PhDY	O
-	O
Chol	O
before	O
treatment	O
,	O
and	O
arrows	O
indicate	O
LDs	O
with	O
PhDY	O
-	O
Chol	O
after	O
treatment	O
.	O

Green	O
intensity	O
bar	O
shows	O
the	O
ΔI	O
/	O
I	O
value	O
of	O
the	O
SRS	O
image	O
;	O
red	O
intensity	O
bar	O
represents	O
the	O
relative	O
intensity	O
of	O
fluorescence	O
.	O

Image	O
acquisition	O
speed	O
:	O
100	O
μs	O
per	O
pixel	O
for	O
400	O
×	O
400	O
pixels	O
.	O

Scalar	O
bar	O
:	O
10	O
μm	O
.	O

(	O
e	O
)	O
Quantification	O
of	O
PhDY	O
-	O
rich	O
LDs	O
in	O
the	O
cells	O
before	O
and	O
after	O
HPβCD	O
treatment	O
(	O
n	O
=	O
7	O
).	O

Error	O
bars	O
represent	O
standard	O
deviation	O
.	O
**:	O
p	O
<	O
0	O
.	O
005	O
.	O

(	O
a	O
)	O
SRS	O
images	O
of	O
live	O
wildtype	O
and	O
ChUP	O
-	O
1	O
deleted	O
C	O
.	O
elegans	O
fed	O
with	O
PhDY	O
-	O
Chol	O
(	O
500	O
μM	O
)	O
for	O
3	O
days	O
.	O

Arrows	O
indicate	O
PhDY	O
-	O
rich	O
particles	O
in	O
the	O
intestine	O
.	O

Image	O
acquisition	O
speed	O
:	O
40	O
μs	O
per	O
pixel	O
for	O
400	O
×	O
400	O
pixels	O
.	O

Scalar	O
bar	O
:	O
10	O
μm	O
.	O

(	O
b	O
)	O
TPEF	O
and	O
SRS	O
images	O
of	O
live	O
hjIs9	O
[	O
ges	O
-	O
1p	O
::	O
glo	O
-	O
1	O
::	O
GFP	O
+	O
unc	O
-	O
119	O
(+)]	O
worm	O
fed	O
with	O
PhDY	O
-	O
Chol	O
(	O
500	O
μM	O
)	O
for	O
3	O
days	O
.	O

Arrows	O
indicate	O
the	O
PhDY	O
-	O
rich	O
particles	O
in	O
LROs	O
.	O

Image	O
acquisition	O
speed	O
:	O
40	O
μs	O
per	O
pixel	O
for	O
400	O
×	O
400	O
pixels	O
.	O

Scalar	O
bar	O
:	O
10	O
μm	O
.	O

